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Abstract 
Background 
The bacterial genus Mycobacterium is of great interest in the medical and biotechnological 
fields. Despite a flood of genome sequencing and functional genomics data, significant gaps 
in knowledge between genome and phenome seriously hinder efforts toward the treatment of 
mycobacterial diseases and practical biotechnological applications. In this study, we propose 
the use of systematic, comparative functional pan-genomic analysis to build connections 
between genomic dynamics and phenotypic evolution in polycyclic aromatic hydrocarbon 
(PAH) metabolism in the genus Mycobacterium. 
Results 
Phylogenetic, phenotypic, and genomic information for 27 completely genome-sequenced 
mycobacteria was systematically integrated to reconstruct a mycobacterial phenotype 
network (MPN) with a pan-genomic concept at a network level. In the MPN, mycobacterial 
phenotypes show typical scale-free relationships. PAH degradation is an isolated phenotype 
with the lowest connection degree, consistent with phylogenetic and environmental isolation 
of PAH degraders. A series of functional pan-genomic analyses provide conserved and 
unique types of genomic evidence for strong epistatic and pleiotropic impacts on evolutionary 
trajectories of the PAH-degrading phenotype. Under strong natural selection, the detailed 
gene gain/loss patterns from horizontal gene transfer (HGT)/deletion events hypothesize a 
plausible evolutionary path, an epistasis-based birth and pleiotropy-dependent death, for PAH 
metabolism in the genus Mycobacterium. This study generated a practical mycobacterial 
compendium of phenotypic and genomic changes, focusing on the PAH-degrading 
phenotype, with a pan-genomic perspective of the evolutionary events and the environmental 
challenges. 
Conclusions 
Our findings suggest that when selection acts on PAH metabolism, only a small fraction of 
possible trajectories is likely to be observed, owing mainly to a combination of the 
ambiguous phenotypic effects of PAHs and the corresponding pleiotropy- and epistasis-
dependent evolutionary adaptation. Evolutionary constraints on the selection of trajectories, 
like those seen in PAH-degrading phenotypes, are likely to apply to the evolution of other 
phenotypes in the genus Mycobacterium. 
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Background 
Mycobacterium is the single genus in the family Mycobacteriaceae, in the order 
Actinomycetales [1]. There are more than 150 recognized parasitic and free-living species of 
Mycobacterium (http://www.bacterio.cict.fr/m/mycobacterium.html) with remarkable 
metabolic and physiologic versatility, enabling colonization of diverse habitats [2,3]. There 
has been great interest in mycobacteria due to their abilities both to cause devastating 
diseases in humans and animals and to degrade toxic compounds in the environment [4,5]. 
For these reasons, the number of available genome sequences has been growing fast and 
genome-scale omics data have been generated, allowing deeper functional genomics insights 
into their phenotypic features [6-13]. Several mycobacterial models have played an important 
role in the functional genomics understanding of basic phenotypic traits. For example, M. 
tuberculosis and M. leprae, for mycobacterial pathogenicity, and M. vanbaalenii PYR-1, for 
high-molecular-weight (HMW) PAH biodegradation, have been studied and the accumulated 
information has been applied to obtain information on other species [3,5,14,15]. However, 
despite the exciting discoveries continually adding to the broader and deeper knowledge of 
mycobacteria, there is a significant knowledge gap between genome and phenome in the 
genus Mycobacterium, due mainly to the epistatic and pleiotropic complexity of the genomic 
and phenotypic traits. The epistatic interaction—functional combination of two or more genes 
(or enzymes) for a single trait (or phenotype)—and pleiotropic activity—functional 
contribution of a gene (or enzyme) for multiple traits (or phenotypes)—are still poorly 
understood at the genome level [16] but are essential for a deeper understanding of 
mycobacterial systems. 
Newly arising genomic variations create phenotypic changes upon which natural selection 
can act. The evolutionary genetics of epistasis and pleiotropy not only make their effects on 
evolution difficult to predict, but also constrain the path of natural selection, which allows 
observation of only a small fraction of possible evolutionary trajectories [16]. In this respect, 
mycobacterial HMW PAH degradation is of particular interest, because of the metabolic 
ambiguity (as nutrient or toxicant) (Figure 1) and the environment-dependent availability of 
HMW PAHs [8]. As shown in Figure 1, PAHs serve not only as nutrients to be metabolized 
but also as potential toxicants if they are transformed to diol-epoxides by metabolic activation 
[17-19]. PAHs consist of two or more fused aromatic rings arranged in various configurations 
[20]. Although PAHs are introduced into the environment mainly from anthropogenic routes, 
they are also found occurring naturally in the environment. Since physical and chemical 
characteristics of PAHs vary with molecular weight, PAHs can be divided into two groups, 
low-molecular-weight PAHs (LMW PAHs), with two or three fused aromatic rings, and 
HMW PAHs, with four or more fused aromatic rings. HMW PAHs are more toxic and 
difficult to degrade, persisting longer than LMW PAHs in the environment [20]. Microbial 
metabolic activity represents one of the primary processes of degradation and transformation 
of PAHs in the environment [20], and some members of the genus Mycobacterium have been 
shown to be able to degrade HMW PAHs [12,21,22]. Therefore, a possible full evolutionary 
scenario for PAH metabolism in the genus Mycobacterium could provide deeper insights into 
the relationship between genomic variations and natural selection. 
Figure 1 Metabolic ambiguity of PAHs as nutrient or toxicant. The ring-cleavage process 
(RCP)—mono- or dioxygenation by ring-hydroxylating oxygenases (RHOs) or cytochrome 
P450 monooxygenases (CYPs), dehydrogenation by dihydrodiol dehydrogenase, and ring-
cleavage by ring-cleavage dioxygenase—in mycobacterial PAH metabolism responsible for 
metabolic benefits is in the green colored area, while production of toxic PAH 
metabolites/byproducts and reactive oxygen species (ROS), which have the potential to cause 
PAH-adducts and oxidative DNA damage, is in the red colored area. 
M. vanbaalenii PYR-1 has been extensively studied as a model microorganism for bacterial 
HMW PAH degradation at both laboratory and field scales [5,14,15]. Recently, a PAH 
metabolic network (PAH-MN), including HMW PAHs, has been systematically 
reconstructed using genomic, proteomic, and metabolic information [9]. According to the 
PAH-MN, PAH substrates are degraded by a set of interconnected functional processes, 
termed ring-cleavage processes (RCPs), side-chain processes (SCPs), and central aromatic 
processes (CAPs). Under the common aromatic metabolic logic (the activation of benzene 
rings and ring opening), the oxygen-dependent activation of thermodynamically stable 
benzene rings and ring cleavage occurs in RCP, the side chain processing of the opened ring 
to produce biological metabolic precursors occurs in SCP, and the metabolic connection of 
protocatechuate to the tricarboxylic acid (TCA) cycle occurs in CAP. In our previous study 
with M. vanbaalenii PYR-1, a fundamental building principle of the PAH-MN, a patchwork 
assembly of the phylogenetic modules, with a backward evolutionary direction from CAP via 
SCP to RCP, has been hypothesized on the basis of the functional association of the 
phylogenetic modules [9]. When considering the ambiguous metabolic effects of HMW 
PAHs, the model microorganism can benefit from the buildup of the PAH-MN in both 
architectural and functional aspects. That is, the directed growth of the metabolic network 
from CAP via SCP to RCP increases the architectural and functional connectivity among 
phylogenetic modules with PAH-degrading enzymes, resulting in decreasing the 
epimetabolome, including toxic intermediates, such as diol epoxides [9]. Therefore, the 
backward evolutionary growth of the PAH-MN can also have a practical toxicological benefit 
that minimizes toxic effects of the activated PAH intermediates, which are produced in RCP. 
As revealed in the proteomic analysis of the PAH-MN, function-specific regulation of the 
functional modules (RCP, SCP, and CAP) completes the evolutionary and metabolic 
endeavors for nutritional benefits from PAHs, by allowing mature metabolic behavior of the 
channel management for global PAH metabolism with more productivity and less toxicity 
(that is, generating more productive biological precursors, such as pyruvate and acetyl-CoA, 
and fewer toxic intermediates, such as o-quinones) [9]. Therefore, it is evident that 
mycobacterial PAH metabolism is an epistasis-centric phenotype, which is essential for 
functional combination of two or more genetic modules and requires active investment to 
obtain and continuous, sophisticated management to keep. However, no pan-genomic 
evidence has been evaluated for this hypothesis, and consequently, a full evolutionary story 
of the PAH-degrading phenotype in the genus Mycobacterium has not been proposed. 
Phenotypic traits of living cells are the result of successful functional interactions among 
biochemical compounds in highly complex biochemical networks [9,23]. It is a major 
challenge to understand causes and consequences of evolution of the phenotypes. In this 
study, to retrace plausible evolutionary trajectories of PAH metabolism in the genus 
Mycobacterium with no anthropomorphic bias, we employed three key concepts: networks, 
pan-genomic comparison, and functional genomics. First, networks allow for intuitive 
platforms for connection and visualization of the interacting parts with a more holistic view 
of phenotypic interactions in the MPN and functional interactions of the genetic modules in 
the PAH-MN. Second, pan-genomic comparison of the mycobacterial genomes, which 
exhibit extreme levels of evolutionary plasticity with high levels of gene gain and loss during 
evolution [24], allows integrating the genome sources to increase the power of genomic 
analyses. Finally, functional genomic data (proteomic data in this study) filter out the static 
genes that are not expressed and so may not be involved in a given phenotype from the pan-
genomic data to provide phenotype-related functional pan-genomic dynamics. This 
multidisciplinary approach, which requires intensive systematic integration of the three 
different types of data, was essential to elucidate the nature and underlying mechanisms, and 
the phenotypic feedbacks, of epistatic and pleiotropic evolutionary effects of PAH 
metabolism in the genus Mycobacterium. 
Results and discussion 
Systematic integration of data 
In this study, initially, phylogeny, phenotypes, and genomic contents of 27 completely 
genome-sequenced mycobacteria were systematically integrated to generate an applicable 
mycobacterial compendium of phenotypic and genomic properties (Table 1). On the basis of 
the integrated information, an MPN was reconstructed and analyzed from a pan-genomic 
perspective. A series of consecutive functional pan-genomic analyses provided conserved and 
unique genomic evidence for strong epistatic and pleiotropic impacts on the evolutionary 
trajectories of the PAH-degrading phenotypes in the genus Mycobacterium. 
Table 1 Phenotypic and genomic properties of the 27 completely genome-sequenced strains of mycobacteria 
Mycobacterial strain Phenotypic properties Genomic properties Reference 
Life-stylea Growth rate Pathogenicity PAH-metabolism Genome size GC % Gene Count COG Count 
Mycobacterium smegmatis MC2 155 FL Fast Non-pathogenic PAH-non-degrading 6988209 0.67 6941 4796 [25] 
Mycobacterium vanbaalenii PYR-1 FL Fast Non-pathogenic PAH-degrading 6491865 0.68 6047 4186 [26,27] 
Mycobacterium sp. KMS FL Fast Non-pathogenic PAH-degrading 6256079 0.68 6089 4135 [12] 
Mycobacterium sp. JLS FL Fast Non-pathogenic PAH-degrading 6048425 0.68 5855 4148 [12] 
Mycobacterium gilvum PYR-GCK FL Fast Non-pathogenic PAH-degrading 5982829 0.68 5683 3901 [28] 
Mycobacterium sp. MCS FL Fast Non-pathogenic PAH-degrading 5920523 0.68 5704 3955 [12,29] 
Mycobacterium gilvum Spyr1 FL Fast Non-pathogenic PAH-degrading 5783292 0.68 5434 4038 [13] 
Mycobacterium sp. JDM601 FHA Slow Pathogenic PAH-non-degrading 4643668 0.68 4398 3162 [30] 
Mycobacterium marinum M, ATCC BAA-535 FHA Slow Pathogenic PAH-non-degrading 6660144 0.66 5501 3717 [31] 
Mycobacterium ulcerans Agy99 FHA Slow Pathogenic PAH-non-degrading 5805761 0.65 4306 2853 [32,33] 
Mycobacterium avium 104 FHA Slow Pathogenic PAH-non-degrading 5475491 0.69 5305 3504 [34,35] 
Mycobacterium abscessus CIP 104536 FHA Fast Pathogenic PAH-non-degrading 5090491 0.64 4991 3301 [36] 
Mycobacterium avium subsp. paratuberculosis K-10 FHA Slow Pathogenic PAH-non-degrading 4829781 0.69 4415 3188 [37-39] 
Mycobacterium canettii CIPT 140010059 FHA Slow Pathogenic PAH-non-degrading 4482059 0.66 3909 2949 [40] 
Mycobacterium tuberculosis F11 (ExPEC) FHA Slow Pathogenic PAH-non-degrading 4424435 0.66 4019 2791 [41] 
Mycobacterium tuberculosis H37Ra FHA Slow Pathogenic PAH-non-degrading 4419977 0.66 4099 2811 [42-44] 
Mycobacterium tuberculosis H37Rv (lab strain) FHA Slow Pathogenic PAH-non-degrading 4411532 0.66 4062 2807 [44] 
Mycobacterium tuberculosis CCDC5180 FHA Slow Pathogenic PAH-non-degrading 4405981 0.66 3639 2836 [40,45,46] 
Mycobacterium tuberculosis CDC1551 FHA Slow Pathogenic PAH-non-degrading 4403706 0.66 4300 2716 [47,48] 
Mycobacterium tuberculosis CCDC5079 FHA Slow Pathogenic PAH-non-degrading 4398812 0.66 3695 2875 [49] 
Mycobacterium tuberculosis KZN 1435 (MDR) FHA Slow Pathogenic PAH-non-degrading 4398250 0.66 4107 2799 [25,29] 
Mycobacterium africanum GM041182 FHA Slow Pathogenic PAH-non-degrading 4389314 0.66 3880 2896 [50,51] 
Mycobacterium bovis BCG Pasteur 1173P2 FHA Slow Pathogenic PAH-non-degrading 4374522 0.66 4048 2783 [42,43] 
Mycobacterium bovis BCG Tokyo 172 FHA Slow Pathogenic PAH-non-degrading 4371711 0.66 3996 2776 [52] 
Mycobacterium bovis AF2122/97 FHA Slow Pathogenic PAH-non-degrading 4345492 0.66 4014 2760 [53] 
Mycobacterium leprae TN OI Slow Pathogenic PAH-non-degrading 3268203 0.58 2750 1175 [53-55] 
Mycobacterium leprae Br4923 OI Slow Pathogenic PAH-non-degrading 3268071 0.58 1654 1173 [56] 
aFL, free-living; FHA, facultatively-host-associated; OI, obligately intracellular. 
A compendium of phenotypic and genomic changes on the bases of phylogeny, 
genomic contents, and phenotypes in the genus Mycobacterium 
In this study, several types of information, including phylogenetic, genomic and phenotypic 
traits, were integrated to offer a rational comparative clustering of the 27 mycobacterial 
strains (Table 1), which allowed the following systematic pan-genomic analyses of the 
evolutionary events in terms of mycobacterial PAH metabolism. Figure 2 shows 
comprehensive relationships of the 27 mycobacterial strains with respect to phylogeny, 
genome, and phenotypic traits. 
Figure 2 Clustering and pan-genomic change of the 27 fully genome-sequenced 
mycobacteria. (A) Maximum likelihood tree was constructed by concatenation of the 22 
conserved genes in the 27 mycobacteria (available on TreeBASE S16971). The tree was 
rooted using the free-living M. smegmatis MC2 155, with the largest genome size, as an 
outgroup. The branches were annotated with bootstrap support. (B) Effect on the pan- and 
core genome dynamics found by a progressive addition of genomes based on phylogeny. (C) 
Dichotomous phenotype clustering corresponding to phylogeny for lifestyle, growth rate, 
pathogenicity, PAH-metabolism, and plasmid content. (D) Functional clustering of the 27 
mycobacterial genomes based on COG functions. Green circles and red triangles indicate 
free-living and host-dependent lifestyles, respectively. 
Phenotypic dichotomy of the well-characterized 27 mycobacterial strains 
Classical methods to catalogue mycobacteria are based on convenient phenotypic traits, such 
as growth rate, pigmentation, pathogenicity, and specific biochemical properties [57]. For the 
27 mycobacterial strains, lifestyle (free-living, facultatively host-associated, or obligately 
intracellular), growth rate (fast- or slow-growing), and pathogenicity (non-pathogenic or 
pathogenic), together with PAH-degrading ability (PAH-degrading or PAH-non-degrading), 
all of which are fundamentally heterogeneous general phenotypes with low resolution, were 
used in dichotomous keys for two-group groupings and comparisons. 
Traditionally, a major descriptive division of mycobacteria is related to growth rate: the fast-
growers (colonies seen within 7 days) and the slow-growers (colonies not seen within 7 days) 
[2,3]. Out of the 27 mycobacteria, M. smegmatis [25], M. gilvum [13], M. vanbaalenii 
[26,27], M. abscessus [36] and Mycobacterium sp. strains MCS [12,29], KMS [12], and JLS 
[12] are fast-growers, whereas other mycobacteria, including M. avium [34,35], M. ulcerans 
[32,33], M. marinum [31], M. canettii [40], the M. tuberculosis complex (with M. bovis and 
M. africanum) [8,16,24,25,29,40-53], and M. leprae [37,54-56], are slow-growers. On the 
basis of pathogenicity, all slow-growing mycobacteria are known to be associated with 
human or animal diseases, whereas the group of fast-growing mycobacteria has only one 
important human pathogen, M. abscessus [36]. Non-pathogens and fast-growers are free-
living (FL), whereas all pathogenic mycobacteria are either host-dependent, facultatively-
host-associated (FHA), or obligate intracellular (OI) parasites. All mycobacteria that degrade 
PAHs have overlapping phenotypic features; they are fast-growing, non-pathogenic and free-
living. One or more plasmids are found in many free-living mycobacteria, particularly in the 
PAH-degraders, and in a few pathogenic FHA mycobacteria, but not in the M. tuberculosis 
complex [16,24,25,29,40-53] or M. leprae [37,54-56]. 
Phylogeny of the 27 mycobacterial strains 
Compared with a 16S rRNA-based tree (data not shown), despite its significant structural 
similarity, the evolutionary reconstruction based on the concatenation of the sequences of 22 
conserved genes (in the core genome of the 27 mycobacterial genomes) substantially 
enhanced the vertical phylogenetic resolution (Figure 2A, available on TreeBASE S16971). 
The enhanced discriminatory power was able to segregate the pathogenic and PAH-non-
degrading M. abscessus from the cluster of PAH-degrading strains in the tree. Therefore, the 
concatenated sequence-based phylogeny was in congruence with the phenotypic traits, 
lumping groups of mycobacterial strains together that have common phenotypic 
characteristics, in terms of lifestyle, growth rate, pathogenic characteristics, and PAH-
metabolic capabilities (Figure 2C). The depth of phylogeny could function as a threshold to 
classify the genus Mycobacterium at the degree of phenotypic dichotomy. In the case of 
growth rate, the fast-growing mycobacteria are more deeply branched to the left of the tree, 
separated from the slow-growing strains, which form monophyletic clusters with a high intra-
cluster relationship (Figure 2A). Here, the fast-growing but pathogenic M. abscessus is 
positioned between the fast-growing PAH-degraders and the slow-growing pathogenic 
Mycobacterium sp. JDM601 (Figure 2A and C). The six well-known PAH-degrading 
mycobacteria are grouped into an isolated cluster embedding M. vanbaalenii PYR-1 (Figure 
2A and C). As illustrated in Figure 2A, the distinction between PAH-degraders and PAH-
non-degraders can also be easily made on the threshold of the red dashed line. The 27 
mycobacteria were clustered into 3 groups (M. smegmatis, the six PAH-degraders, and the 
twenty PAH-non-degrading pathogens), in which members belonging to the same clusters 
shared the same PAH-degrading metabolic capability. 
Overall, the concatenation of the conserved genes enhanced discriminatory resolution of the 
mycobacterial phylogeny, and despite their polyphyletic and heterogeneous properties, the 
phenotypes as dichotomous keys for two-group groupings and comparisons function well as a 
reliable indicator of phylogenetic relationships in the tree, greatly facilitating the phenotypic 
delineation of clusters. Especially, the combination of the phylogeny and the phenotypic 
dichotomy provided a global view for the evolutionary process and direction of the genus 
Mycobacterium. Therefore, the integrated use of phenotypic and genotypic (or genomic) 
traits was essential for better understanding and dissecting of the heterogeneity of the 
phenotypes at the genomic (or pan-genomic) perspective, which is a key for tracing the 
evolutionary events. 
Pan-genomic dynamics according to the phylogeny of the 27 mycobacterial 
strains 
The structure and phenotypic behavior of the phylogeny for the genus Mycobacterium agree 
with the proposed model of bacterial evolution: from free-living organisms with larger 
genomes to host-dependent pathogenic organisms with smaller genomes [58,59]. Based on 
the observed genome alteration, it could be inferred that the genome dynamics reflected 
selective environmental forces, which defined the degree of diversity and dynamics of 
genomes corresponding to phenotypic evolution. 
On the basis of the pan-genomic concept [60,61], genome dynamics according to the 
phylogeny of the 27 mycobacteria were measured to assess the evolutionary scale against 
which the evolutionary steps led to the contemporary genomes. As shown in Figure 2B and 
C, the mycobacterial pan-genome shows initially ‘open’ but later ‘closed’ pan-genomic 
properties. The size of the pan-genome increased rapidly at the beginning from M. smegmatis 
to M. marinum via the six PAH-degraders (‘open’ pan-genome added approximately 11,686 
new genes), but the number of genes added to the pan-genome was comparatively much 
smaller with the genomes of pathogenic strains of the M. africanum, M. bovis, and M. 
tuberculosis clade (‘closed’ pan-genome added only 1,363 genes). On the other hand, the 
core-genome dropped significantly in size after the addition of the first PAH-degrader 
Mycobacterium sp. MCS (loss of 2,973 genes) and the first pathogen, M. abscessus (loss of 
1,005 genes). Another noticeable drop was observed in the OI parasite M. leprae genome 
(loss of 425 genes), which is consistent with the phenotypic changes. Interestingly, M. 
abscessus, M. avium, Mycobacterium sp. JDM601, M. ulcerans, and M. marinum were 
scattered away from the stable clusters of the six PAH-degrading mycobacteria and the 12 M. 
tuberculosis complex strains (Figure 2A and D). The mycobacteria (M. abscessus, M. avium, 
Mycobacterium sp. JDM601, M. ulcerans, and M. marinum) showed a continuous, rapid pan-
genome growth, which was followed by a relatively stable size of core-genome after the 
transient decline by M. abscessus. On the contrary, the 12 M. tuberculosis complex strains, 
with close phylogenetic relationships, showed stable sizes of pan- (only avg. 110 genes 
increasing) and core-genomes (only avg. 10 genes decreasing), leading to a ‘closed’ pan-
genome. The core-genome and pan-genome for all 27 mycobacterial genomes were estimated 
to be approximately 925 and 20,342 genes, respectively. 
In pan-genomic increase, the six PAH-degraders showed an ‘open’ pan-genomic property, a 
continuous and gradual pan-genome growth, which added approximately 5,320 new genes. 
The addition of the first Mycobacterium sp. MCS to the genome of the PAH-non-degrading 
M. smegmatis contributed 1,870 new genes to the pan-genome. With the five PAH-degrading 
genomes, the pan-genome grew by an average of 690 (±367) genes every time a new genome 
was added. On the other hand, after the first Mycobacterium sp. MCS caused a significant 
drop (loss of about 2,973 genes) in the core genome, additional genomes of the PAH-
degrading mycobacteria had a minimal effect on the core-genome, which indicates that the 
core-genome size is relatively static. Since the genomes are similar in size, a continuous and 
rapid pan-genomic increase while maintaining a stable core-genome indicates a high 
variability of dispensable (found in one or more but not all genomes) parts of the genomes of 
PAH-degrading mycobacteria. Overall, the pan-genomic features of the PAH-degraders, the 
apparent drop of the core-genome in size and the continuous and rapid growth of the pan-
genome agree well with their phylogenetic and phenotypic isolation in the genus 
Mycobacterium. 
Functional clustering analysis based on the genomic contents of the 27 
mycobacterial strains 
To visualize the function-based genomic comparison of the 27 mycobacteria, which evolve 
through vertical inheritance and horizontal gene transfer (HGT), genomes were clustered 
based on similar functional profiles. In general, as shown in the principal components 
analysis (PCA) clustering (Figure 2D), the vertical phylogenetic relevance was well 
conserved in the cluster structure, based on the genomic clusters of orthologous groups 
(COG) content distance, and enriched the genome-scale perspective of lateral evolution at a 
functional level. In addition, the proximity of clustering accounted well for not only the pan-
genomic dynamics but also the phenotypic features of the 27 mycobacteria at the genus level. 
For instance, when clustered by the blue threshold line in the phylogenetic tree (Figure 2A), 
the clade of 20 PAH-non-degrading pathogenic mycobacteria was further divided into 7 
clusters, which provides enhanced discriminatory resolution, reflecting a transitional stage in 
terms of phenotype and pan-genome evolution. In the functional cluster structure, despite the 
conserved phenotypic spectrum, six mycobacteria, M. abscessus, M. avium, M. ulcerans, M. 
avium subsp. paratuberculosis K-10, Mycobacterium sp. JDM601, and M. marinum, were 
dispersed clearly away from the stable clusters of the six PAH-degraders and the M. 
tuberculosis complex and M. leprae, the OI parasites (Figure 2D). 
Consistent with the phylogenetic affinity and pan-genomic properties, the six PAH-degrading 
mycobacteria were clustered together, indicating that they share similar functional genomics 
inventories. Interestingly, despite its significant vertical phylogenetic distance and pan-
genomic difference, the PAH-non-degrading M. smegmatis was also in close proximity to the 
cluster of four PAH-degrading mycobacteria (strains KMS, PR-GCK, PYR-1 and MCS). The 
closer proximity of the PAH-non-degrader to four of the PAH-degraders than to the other 
PAH-degrader, Mycobacterium sp. JLS, indicates a high degree of functional genomics 
similarity between M. smegmatis and the four PAH-degrading strains (Figure 2D) and, as 
revealed by the following genomic analysis, M. smegmatis also had several genes involved in 
PAH degradation. The observed functional genomics distance suggests that the PAH-
degraders share similar genetic and physiological backgrounds for successful microbial 
metabolism of PAHs, which is apparently an attractive phenotype to mycobacteria in an 
oligotrophic habitat highly contaminated with PAHs [21]. 
Reconstruction of a mycobacterial phenotype network (MPN) for the genus 
Mycobacterium 
Phenotype networks (PNs) describe the interconnectivity among phenotypic traits. They have 
been shown to be important in better understanding complex epistatic and pleiotropic 
behaviors of biological systems from a global perspective [23]. To decipher the genomic 
epistasis and pleiotropy for mycobacterial phenotypic evolution in terms of PAH degradation, 
we first reconstructed an MPN and then performed sequential functional pan-genomic 
comparison, using the phenotype nodes to elucidate emerging properties of the MPN as a 
whole. The MPN was reconstructed from vertical phenotypic interrelationships as well as 
horizontal phenotype dichotomy, which accounts for the mutual effects on phenotypic 
evolution (Figure 3). 
Figure 3 Mycobacterial phenotype network (MPN) of the 27 mycobacteria. The number 
of mycobacteria belonging to the phenotype is given in brackets after each name of a 
phenotype node (blue ellipse). In the MPN, the node shapes of the 27 mycobacterial strains 
were represented based on the 9-phenotype classification as explained in the text: diamond, 
FL; hexagon, PAH-degrading; octagon, Non-pathogenic; parallelogram, Fast-growing; 
rectangle, FHA; triangle, PAH-non-degrading; round rectangle, Pathogenic; v, Slow-
growing; ellipse, OI. Together with the numerical connection strength score (in red), the 
thickness of the connection lines (edge, blue) among the phenotypes indicates the degree of 
the connection strength. In the MPN, the phenotypes FL and Non-pathogenic show the 
highest connection strength [CS (Gx, Gy), 100], while Fast-growing (8)—Pathogenic (20), 
Fast-growing (8)—FHA (18), FL (7)—PAH-non-degrading (21), and Non-pathogenic (7)—
PAH-non-degrading (21) show weak connection strength [8.8 < CS (Gx, Gy) < 9.5]. 
The topological structure of the MPN clearly indicates that the mycobacterial phenotypes are 
linked with scale-free features: (i) preferential linking among phenotype nodes and (ii) a 
strongly connected hub phenotype node. In the MPN, all phenotype nodes apparently show 
lifestyle-centric preferential connections, reflecting their phenotypic relationship; three nodes, 
‘PAH-degrading’, ‘Fast-growing’, and ‘Non-pathogenic’ are connected to each other with the 
center at the ‘Free-living (FL)’ node, whereas the other three nodes, ‘Pathogenic’, ‘PAH-non-
degrading’, and ‘Slow-growing’ are linked to each other with centers at the ‘facultatively-
host-associated (FHA)’ and ‘obligately intracellular (OI)’ nodes (Figure 3). In the MPN, most 
phenotypes showed strong connectivity, with the exception of the phenotype ‘Fast-Growing’. 
The phenotype ‘Fast-growing’ is strongly linked to the ‘Free-living (FL)’-centric nodes 
(‘PAH-degrading’ and ‘Non-pathogenic’) but has a weak connection to the phenotypes, 
‘FHA’ and ‘Pathogenic’. The weak connection of the phenotype node ‘Fast-growing’ toward 
‘FHA’ and ‘Pathogenic’ caused by M. abscessus, which is a fast-growing but facultatively-
host-associated pathogenic mycobacterium. Together with M. abscessus, medically important 
fast-growing pathogenic mycobacteria are essentially limited to M. chelonae and M. 
fortuitum, which are associated with traumatic and surgical wound infections, skin and soft 
tissue infections, and pulmonary disease [62]. It should be noted that the weak connection of 
the node ‘PAH-non-degrading’ with the ‘Fast-growing’ and ‘Non-pathogenic’ nodes resulted 
from narrow observation caused by the limited number of available mycobacterial genomes. 
As revealed in the comprehensive topological structure of the MPN, therefore, the phenotype 
‘Fast-growing’ shows a transitional phenotypic relationship, bridging the different lifestyle-
centric phenotype nodes, which is consistent with its phylogenetic and functional positions. 
Another interesting finding was that the phenotype ‘PAH-non-degrading’ is a hub phenotype 
in the MPN with the highest connection degree of 7 (Figure 3). Consistent with the highest 
phenotypic compatibility of the hub node, its dichotomy phenotype ‘PAH-degrading’ is a 
relatively specific and isolated phenotype in the MPN. The ‘PAH-degrading’ node has the 
lowest connection degree of 3 and an apparently biased connection toward the other two FL-
centric phenotypic nodes, ‘Fast-growing’ and ‘Non-pathogenic’. That is, the ‘PAH-
degrading’ node has no connection with the phenotypes ‘Pathogenic’ and ‘Slow-growing’, 
which are the main phenotypic traits of the ‘FHA’ and ‘OI’ mycobacteria. These connection 
features of the ‘PAH-degrading’ node in the MPN suggest that PAH degradation might be an 
isolated specific phenotype, limited to a phylogenetically isolated group of mycobacteria. 
Overall, together with a useful mycobacterial compendium of phenotypic and genomic 
properties (Figure 2), the apparent lifestyle-dependent phenotypic connection of the MPN 
provides global insights into the direction of phenotypic evolution, including PAH 
degradation, in the genus Mycobacterium. In addition, network features of the ‘PAH-
degrading’ phenotype in the MPN suggest a relatively low degree of robustness in the face of 
genetic and environmental changes. 
Pan-genomic perspective of the MPN 
The pan-genomic comparison (core- and pan-genomes) of the phenotypic nodes not only 
further supports the interrelationships and stability of the phenotype nodes in the MPN but 
also allows better understanding of the relative roles of the core- and dispensable-genomes in 
phenotype evolution. For quantitative comparison of the phenotypic nodes, we extended the 
pan-genomic concept to the MPN. As revealed in the pan-genomic comparison (Figure 4A), 
the ‘Free-living (FL)’-centric phenotype nodes have a relatively large core-genome but a 
small dispensable-genome compared to the ‘FHA’- and ‘OI’-centric nodes. For instance, the 
seven sympatric mycobacteria belonging to the ‘FL’ node have a relatively large genome size 
and core-genome than those of the two allopatric strains in the ‘OI’ node. In addition, there is 
an association between connectivity of the phenotype nodes and their pan-genomic size, in 
which the phenotypic nodes with strong connectivity in the MPN show a similar pan-genome 
size (Figure 4A). The three nodes ‘PAH-degrading’, ‘Free-living (FL)’ and ‘Non-pathogenic’ 
show a similar pan-genome to core-genome ratio, which are 9,532/3,533 for the ‘PAH-
degrading’ node and 11,878/3,085 for the ‘FL’ and ‘Non-pathogenic’ nodes. The ‘Fast-
growing’ is an exception to this, having a relatively small core-genome of 2,072 and a large 
pan-genome of 13,909, which is similar to those of the FHA-centric nodes. The FHA- and 
OI-centric nodes, ‘PAH-non-degrading’, ‘Pathogenic’, and ‘Slow-growing’, have 
significantly bigger pan-genomes but smaller core-genome ratios than those of the ‘FL’-
centric nodes, which are 13,541/958 genes for the ‘PAH-non-degrading’, 13,541/983 genes 
for ‘Pathogenic’, and 11,308/1,077 genes for ‘Slow-growing’. As a result, all FHA- and OI-
centric phenotypic nodes have relatively small core-genomes but large dispensable genomes, 
which indicate a high degree of genome diversity of the phenotype node. Most of all, the 
bigger core-genome size of the ‘FL’-centric nodes than those of the ‘FHA’- and ‘OI’-centric 
nodes results from both higher numbers of genes per genome and genomic similarity. It 
suggests that the relatively small core-genome and large pan-genome of the ‘Fast-growing’ 
node definitely resulted from inclusion of M. abscessus, which is distant from other free-
living mycobacteria in terms of phylogeny and phenotype. 
Figure 4 Comparative pan-genomics based on the MPN. (A) Pan-genomic comparison 
(core- and pan-genome) of the phenotype nodes in the MPN. The open and closed circles 
indicate the number of genes of the pan-genome and core-genome of each phenotypic node, 
respectively. The pan- (open circle) and core-genome (closed circle) of the phenotype node 
OI overlapped. (B) Venn diagram analysis of the core genomes of the three phenotype nodes 
in the FL-centric sub-MPN. 
In the ‘PAH-degrading’ node, the pan-genome contains 9,532 genes, of which 3,533 genes 
belong to the core-genome that is present in each strain and 5,999 genes belong to the 
dispensable genome that is absent in one or more strains (Figure 4A). Except for the node OI, 
the phenotype ‘PAH-degrading’ node shows the smallest pan-genome and dispensable 
genome and the largest core-genome. This pan-genomic feature clearly suggests a high 
degree of genomic similarity between members of the PAH-degraders and the core-genome 
with unique genes, essential for the ‘PAH-degrading’ phenotype. A Venn diagram analysis 
using the core-genomes of the ‘FL’-centric phenotype nodes revealed that the ‘PAH-
degrading’ node has several hundred unique genes (Figure 4B). Out of 448 unique genes, 
about 34 genes encode the catabolic enzymes involved in RCP (18, 53%), SCP (12, 35%), 
and CAP (4, 12%) that are responsible for PAH metabolism in M. vanbaalenii strain PYR-1, 
whereas about 415 genes encode enzymes for diverse cellular functions, such as 143 genes 
(35%) for cellular metabolism (MET), 44 genes (11%) for information storage and 
processing (ISP), 57 genes (14%) for cellular processes and signaling (CPS), and 90 genes 
(22%) that are poorly characterized. Consistent with the pan-genomic properties of the ‘PAH-
degrading’ node, its dichotomy phenotype node, ‘PAH-non-degrading”, shows the smallest 
core-genome of 958 genes and largest pan-genome of 13,541 genes. The pan-genomic 
features of the ‘PAH-degrading’ node are consistent with the monophyletic affinity in 
phylogeny and the biased connection preference to the phenotype nodes (‘FL’, ‘Non-
pathogenic’, and ‘Fast-growing’ nodes) with similar pan-genomic sizes in the MPN. 
Functional pan-genomic view of the six PAH-degraders with PAH-degrading 
phenotype in the MPN 
For functional pan-genomic understanding of the PAH-degrading phenotype, we investigated 
the pan-genome of the six PAH-degrading mycobacteria in the ‘PAH-degrading’ node based 
on the previous proteomic data from M. vanbaalenii PYR-1 [9]. As shown in Figure 5A and 
Additional file 1: Table S1-S5, we categorized the pan-genome of 9,532 genes from the six 
strains, among which 3,533 genes were considered to be core genome and 5,999 genes were 
dispensable genome. The core-genome accounted for 37% of the pan-genome and, as shown 
in functional analysis, shows a distribution across all COG categories (Figure 5B; Additional 
file 1: Tables S1 and S2). 
Figure 5 Systematic genome analyses of the six PAH-degrading mycobacteria. (A) Pan-
genome of the six PAH-degrading mycobacteria. (B) Functional classification of the 3,533 
core-genome based on COG category. (C) Classification of the 136 catabolic enzymes based 
on functional module and enzyme function in PAH-MN. Proteomic expression patterns under 
different aromatic hydrocarbon treatments are also shown. 
Among the 3,533 core genes, 136 genes were tentatively identified to be involved in the 
degradation of aromatic hydrocarbons (Additional file 1: Table S3). According to the 
functional module proposed in the PAH-MN in M. vanbaalenii PYR-1 [9], about 62 genes, 
involved in the functional module RCP, made up the largest portion of the list of 136 genes, 
which is followed by 54 and 20 genes, involved in SCP and CAP, respectively (Figure 5C; 
Additional file 1: Table S4). Especially, as shown in the proteome data (Figure 5C), about 
113 genes out of the 136 genes are expressed as proteins involved in PAH degradation 
pathways (Additional file 1: Table S5) and the expression of these proteins is apparently 
PAH-substrate-regulated. Therefore, this functional genomics observation not only clearly 
indicates that the proteins of the core genome function for PAH-metabolism but also provides 
some insights into the genetic requirements and metabolic potential in terms of PAH 
degradation; they share similar genetic repertoires and PAH metabolic spectra. 
Contribution of HGT events to the PAH-degrading phenotype 
Most free-living mycobacteria are naturally competent, that is, they can take up genetic 
material from the environment and recombine it into their chromosome [63]. Analysis of the 
genome sequences of the PAH-degrading mycobacteria revealed many horizontally acquired 
DNA regions (genomic islands [GIs]) interspersed in their genomes. These GIs are mostly 
larger than 4 kb in length (4 ~ 20 kb in size), with average numbers being 35.8 (±7.5) per 
genome (data not shown). The number of HGT genes identified in the PAH-degrading 
mycobacteria ranged from 437, in M. vanbaalenii PYR-1, to 536, in M. gilvum PYR-GCK 
(average of 480 ± 40), and is 2,878 in total (Figure 6A; Additional file 2: Table S6). Among 
these HGT genes, we identified 754 and 2,124 genes that contribute to the core-genome (a 
total of 3,533 genes) and the dispensable genome (a total of 5,999 genes), respectively 
(Figure 6B; Additional file 2: Tables S7-8). Interestingly, the contribution of the horizontally 
transferred 754 genes to the 5 COG cellular metabolism categories, C, E, F, G, H, and I, was 
339 genes (53%) (Figure 6C), which is apparently higher than that seen in the genomes of 
PAH-degrading mycobacteria (around 30%). It indicates that GIs contribute to the metabolic 
proficiency of these organisms, including the ability to degrade PAHs. 
Figure 6 Genomic islands (GIs, large-genomic regions that contain multiple genes of 
probable horizontal origin) analysis of the PAH-degrading mycobacteria. (A) 
Comparison of the GIs from the PAH-degrading mycobacteria, depending upon core and 
dispensable genes. (B) HGT contribution of the 2,878 GI-located genes to the pan-genome of 
PAH-degrading mycobacteria. (C) Functional distribution of the 754 horizontally transferred 
genes to the core-genome based on COG. (D) Functional annotation of the horizontally 
transferred PAH-catabolic genes with respect to the general scheme of PAH metabolism 
proposed for M. vanbaalenii PYR-1. Only the 22 genes involved in RCP and SCP are shown. 
Please see reference [9] for a more detailed explanation of the general scheme of 
mycobacterial PAH metabolism. 
Considering only PAH degradation, we identified as horizontally transferred 29 genes, which 
are enough to cover all the enzymatic reactions in the general scheme of PAH degradation 
proposed for M. vanbaalenii PYR-1 (Figure 6D; Additional file 2: Tables S9-10) [9]. Many 
PAH-catabolic genes identified on GIs were also located on the plasmids of PAH-degrading 
mycobacteria, such as Mycobacterium spp. MCS and KMS, which were isolated from 
geographically different locations. Comparison of GIs and PAH-catabolic genes among these 
PAH degraders showed conservation of ~150-kb catabolic gene clusters, with slightly 
different genetic configurations (data not shown). Together with the pan-genomic evidence, it 
strongly demonstrates that most PAH-degrading strains share the same genetic sources and 
pathway evolution by patchwork assembly (assembly of existing pathways in new 
combinations), which has been systematically evaluated as highly successful [9]. It appears 
that the HGT events of the highly conserved PAH-degrading gene clusters could provide 
practical benefits: (i) overcoming evolutionary selective pressure, (ii) acceleration of the 
buildup speed, and (iii) metabolic maximization from the limited genetic modules [9,64]. 
Unique genes in PAH-degrading core-genome but not the pan-genome of 
PAH-non-degraders 
Under dynamic HGT events, the PAH-degrading phenotype might be equally open to all 
mycobacteria. As expected from the pan-genomic view, however, the ‘PAH-degrading’ HGT 
events do not have the same metabolic effects on all competent mycobacteria, because of 
several types of influences, including environment and stochastic, molecular or epigenetic 
variation among individuals [58,65,66]. However, other major influences on HGT events 
could be the genetic backgrounds of competent mycobacteria. To understand the unique 
genetic backgrounds related to the PAH-degrading phenotype, a comparative analysis of the 
core-genome of the ‘PAH-degrading’ node and the pan-genome of the ‘PAH-non-degrading’ 
node was conducted. It led us to find unique genes, which might be directly or indirectly 
related to PAH metabolism, in all PAH-degrading mycobacteria. As shown in Figure 7A and 
Additional file 3: Tables S11-12, about 248 unique genes were identified only in the core-
genome of the PAH-degrading mycobacterial genomes. From the list of 248 unique genes, 
154 genes (62%) were categorized based on COG function or functional modules in the 
PAH-MN, among which 35 genes were assigned to RCP (23 genes), SCP (10 genes), and 
CAP (2 genes) for PAH metabolism [9]. The other 119 genes were assigned to other cellular 
functions (Figure 7B; Additional file 3: Tables S11-12). Interestingly, 46 genes (19%) of the 
unique gene pool were identified as horizontally transferred. When analyzed in terms of 
protein expression, 146 (59%) genes were expressed under all experimental conditions, with 
28 (61% of 46 genes) horizontally transferred genes. 
Figure 7 Identification of the genes found only in the six PAH-degrading mycobacteria. 
(A) Comparison of the core genome of the six PAH-degrading mycobacteria and pan-genome 
of the 20 PAH-non-degrading mycobacteria. (B) Functional classification and their regulation 
of the unique genes in the core genome based on the COG functional category. Please see 
reference [9] for the detailed protein expression information. 
Out of the 23 proteins assigned to the RCP functional module in the PAH-MN, 12 genes 
encode oxygenase components for six ring-hydroxylating oxygenase (RHO) enzyme systems 
[9,67]. Six of the 12 genes encode the RHO components, NidAB, NidA3B3, and PdoA2B2, 
which belong to a type V RHO system, while the other 6 genes encode RHO enzymes 
belonging to a type X RHO system, based on Kweon’s RHO classification [67-69]. Notably, 
these 3 RHOs, NidAB, NidA3B3, and PdoA2B2, have been shown to be the main enzymes 
involved in the initial oxidation of HMW PAHs, such as pyrene and fluoranthene, and LMW 
PAHs, such as phenanthrene, anthracene, and fluorene [5-8,14,15,18,19,67,68,70,71]. 
Overall, it appears that the conserved unique gene pool contained only in the PAH-degraders 
was obtained mainly by HGT events and plays crucial roles in the PAH-degrading phenotype, 
either directly by the PAH-degrading enzymes, such as the three type V RHO systems in the 
RCP functional module, or indirectly by the 120 proteins with versatile cellular functions. As 
revealed in the following gene evolutionary analysis using the Count software [72], 
considering the significant contribution of HGT events to the conserved unique genes, the 
uniqueness of the PAH-degradation genes identified only in the PAH-degraders might be 
explained by gene loss during evolution of the PAH-degrading phenotype under selection. 
When compared with the core-genome of the PAH-degraders, the unique gene pool also 
indicates that PAH-non-degraders also have a significant number of genes directly involved 
in PAH metabolism, which might reveal how closely the PAH-degraders are related to PAH-
non-degraders. 
The presence, organization, and dynamics of PAH-degrading genes in the 
genus Mycobacterium 
To explain the PAH-degrading phenotype and its evolution in the genus Mycobacterium, the 
presence (Figures 8 and 9), organization (Figure 10), and dynamics (gain/loss, Figure 11) of 
the PAH-degrading genes, essential for the complete metabolism of PAHs, were analyzed. To 
address the distribution of PAH-degrading genes and capabilities throughout the genome of 
mycobacteria, the PAH-degrading genes based on functional modules of the PAH-MN were 
surveyed [9]. Interestingly, as revealed in the analysis for the unique genes (Figure 7), most 
putative genes for PAH-degradation are widespread in the genus Mycobacterium. The PAH-
degrading genes identified were between 37 (M. leprae Br4923) and 425 genes 
(Mycobacterium sp. JLS) from the genomes of the 27 mycobacteria (Additional file 4: Table 
S13). Although overall distribution of the catabolic genes among the mycobacteria is 
variable, the clustering results clearly show a correlation between the gene profiles and the 
PAH-degrading ability. As shown in the overall view of the heat map (Figure 8), the six 
PAH-degraders were clustered together to the left, separated from the “PAH-non-degrading” 
strains, suggesting genomic differences in terms of PAH-degradation gene distribution. In 
addition, there is an apparent gradual decrease in the number of genes during evolution from 
‘FL’ to ‘OI’ via ‘FHA’ mycobacteria, with several genes showing apparent gain/loss patterns 
according to PAH-degrading ability (Figures 8, 9, 10, and 11). 
Figure 8 Distribution of PAH-degrading genes across the genus Mycobacterium. The 
genes involved in the PAH-MN were classified based on functional modules and COG 
functional categories. In the cluster analysis of the heat map, the presence/absence pattern of 
the PHA-degrading genes shows apparent relationships with the PAH-degrading abilities and 
lifestyles of the 27 mycobacteria. The six PAH-degraders were grouped together in the left, 
forming a cluster separated from PAH-non-degraders. 
Figure 9 RHO-centric perspective of the 27 mycobacteria. (A) Classification of the 246 
RHO genes identified from the 27 mycobacteria based on Kweon’s classification [67,69] and 
(B) their genomic distribution. Among the classified RHO genes, the type V RHO system 
was the most dominant and concentrated in the six PAH-degrading mycobacterial genomes 
(strains MCS, KMS, JLS, PYR-GCK, Spyr1, and PYR-1). The M. tuberculosis complex and 
the two OI strains, Br4923 and TN, have no genes for type V RHO system. 
Figure 10 Comparison of the phthalate operon (A) and the β-ketoadipate operon (B) in 
the genus Mycobacterium including the six PAH-degraders and the PAH-non-degraders. 
The pht and β-ketoadipate operons, which link the peripheral pathways (RCPs and SCPs) to 
the TCA cycle in the PAH-MN, are conserved in the PAH-degraders, whereas some of the 
PAH-non-degraders, including strains JDM601, 104, and K-10, have a broken operon 
structure. 
Figure 11 Gain and loss of PAH-degrading genes in the genus Mycobacterium. Boxes on 
nodes and tips for the phylogeny show numbers of the PAH-degrading gene groups and 
numbers of the groups with more than one member at least, respectively. Numbers and dots 
on branches indicate the gains and losses of twenty three PAH-degrading gene groups and 
four types of RHO groups, respectively, with blue indicating an overall gain and red an 
overall loss. Roman numerals in the dots indicate type (types II, IV, V and X) of the RHO 
systems based on Kweon’s classification [67,69]. The 27 mycobacteria are color shaded 
according to their lifestyle: green, free-living; blue, facultatively-host-associated; red, 
obligately intracellular. OH-DH4, alcohol dehydrogenase 4; RCD, ring-cleavage 
dioxygenase; PcaG, the alpha subunit of protocatechuate 3,4-dioxygenase; RHO, ring-
hydroxylating oxygenase; OH-DH2, alcohol dehydrogenase 2; PcaI, 3-oxoadipate CoA-
transferase subunit A; PcaJ, 3-oxoadipate CoA-transferase subunit B; PcaL, 3-oxoadipate 
enol-lactone hydrolase/4-carboxymuconolactone decarboxylase. 
In the PAH-MN, the functional module RCP, producing catechols and ring-cleavage products 
from PAH substrates for the following SCP or CAP, is a crucial process that determines 
substrate range and pathways [9]. A set of enzymes, including ring-hydroxylating oxygenases 
(RHOs), cytochrome P450 monooxygenases (CYPs), epoxide hydrolases, cis-dihydrodiol 
dehydrogenases, and ring-cleavage dioxygenases (RCDs), is responsible for RCP [9]. Among 
them, two groups of oxygenases, CYPs and RHOs, are known to initiate mycobacterial PAH 
degradation by ring mono- or di-hydroxylation to form trans- and cis-dihydrodiols, 
respectively [5,8,9,14,15,70,71,73]. In the RHOs, which are the main oxygenases for initial 
PAH oxidation, genome analysis of the 27 mycobacteria predicted the existence of a total of 
246 genes encoding this RHO enzyme, with a range between 0 in M. leprae and 28 in 
Mycobacterium sp. KMS (Figure 9; Additional file 5: Table S14). As illustrated in Figure 9A, 
out of the 246 RHO enzymes based on Kweon’s classification [67,69], 44 RHO enzymes 
were assigned to type II (6 RHOs), type IV (2 RHOs), and type V (36 RHOs), and the rest 
(202 enzymes) were assigned to type X (unclassified RHO) [67,69]. The 36 type V RHO 
systems are dominant and mostly concentrated in the PAH-degraders, which normally have at 
least four or more type V RHO systems (Figure 9B). In particular, 29 type V RHOs out of 32 
are only present in the PAH-degraders (Figure 9A and B). As revealed by the gene gain/loss 
analysis (Figure 11), the fact that the three type V RHOs, two Nid (nidAB and nidA3B3) 
systems and one Pdo (pdoA2B2) system, are consistently present (gained) in the PAH-
utilizing mycobacteria and absent (lost) in PAH-non-degraders, further supports their 
functional importance in PAH metabolism [6,7,9,15,70,71]. Interestingly, together with the 3 
type V RHOs, another type V RHO, a Pht system (phtAaAb), encoding a phthalate 
dioxygenase, is also consistently present in the six PAH-degraders as well as in several PAH-
non-degraders, such as Mycobacterium sp. JDM601, M. avium 104, and M. avium subsp. 
paratuberculosis K-10 (Figures 9 and 10A). A comparison of the operons containing the Pht 
system, however, shows that the pht operons from the PAH-non-degraders do not have two 
genes, phtAc and phtAd, that encode electron transfer components (ETCs), a [3Fe-4S]-type 
ferredoxin and a GR-type reductase, respectively (Figure 10A). The two genes phtAc and 
phtAd comprise a typical type V ETC., which is functionally compatible with type V RHO 
systems [9,67,68]. The absence of the type V ETC. suggests that this incomplete Pht system 
could not function in the hydroxylation of phthalate, which is one of the main hub 
intermediates in the PAH-MN of M. vanbaalenii [8,9]. Furthermore, the significant numerical 
imbalance between oxygenase components and ETCs, the functional loss of type V ETC., 
which has a high degree of compatibility, most likely hinders PAH degradation in these 
PAH-non-degraders. In the genome of M. vanbaalenii, 21 genes were identified to encode 
large subunit components of RHOs, whereas only one copy of the type V ETC. was identified 
[67,68]. Interestingly, RHO enzymes also gradually decrease in numbers during evolution 
from ‘FL’ to ‘OI’ via ‘FHA’ mycobacteria (Figures 9 and 11). In contrast, the number of 
CYPs varies among 27 mycobacterial strains, which means no correlation with PAH-
degrading ability of the strains (Figure 8). However, although few of their physiological roles 
are known, previous studies have proved the involvement of CYP enzymes in the initial 
oxidation of PAHs as an alternative PAH oxygenation reaction [73]. Among the genes 
involved in RCP, the gene encoding RCDs (COG3435) showed the lowest gene copy number 
and only the six PAH-degraders had this RCD gene (Figure 8). 
SCP includes the steps that are responsible for hydrolysis of the α-keto side chain of the ring-
cleaved compounds, forming biological precursors, such as pyruvate, and, at the same time, 
metabolites with an aldehyde group, which should be removed during 
oxidation/decarboxylation in the subsequent reaction [9]. As shown in Figure 8, functionally 
diverse enzymes are included in this functional module. Generally these enzymes show a 
significant numerical abundance with minor exceptions, enabling SCP to accept an enormous 
range of ring-cleavage compounds during PAH metabolism [8,9,18,19]. Two enzymes, the 
decarboxylase (COG0235) and alcohol dehydrogenase (COG2130), are the exceptions to this 
observation; only one or two copies have been found in the genomes of PAH-degraders and a 
few PAH-non-degraders (Figure 8) [9]. Hence, despite these two enzymes’ low gene 
redundancy, their practical functional contribution to diverse substrates with different sizes 
and architecture in the PAH-MN accounts for their substrate diversity and relaxed regulation 
[6,7,9,68]. Interestingly, together with an alcohol dehydrogenase (COG1062, OH-DH2), the 
alcohol dehydrogenase (COG2130, OH-DH4) has been lost during evolution from ‘FL’ to 
‘FHA’ or ‘OI’ mycobacteria (Figure 11). On the contrary, genes encoding catechol-O-
methyltransferase (COMT; EC 2.1.1.6, COG3315), which plays an important role in the 
detoxification of catechols in PAH metabolism [18,19], are more abundant in the genomes of 
PAH-non-degraders (Figure 8), suggesting that some other different functions are probably 
involved in pathogenicity in the pathogenic mycobacteria (Figure 8). Most enzymes 
belonging to SCP, including the decarboxylase, are expressed constitutively, which suggests 
that their regulation is more relaxed than those belonging to the RCP (Figures 5C and 7B). 
The highly conserved catabolic genes responsible for RCP and SCP in the PAH-degraders 
clearly indicate that all six PAH-degraders should convert a broad range of PAHs into 
phthalate, which is the main hub node with an in-degree of 7 and out-degree of 3 in the PAH-
MN from M. vanbaalenii PYR-1 [9]. In addition, a synteny block for the β-ketoadipate 
pathway in the PAH-degraders is conserved (Figure 10B), which further suggests that all 
outgoing metabolic routes from phthalate could be channeled into the β-ketoadipate pathway 
via protocatechuate. Hence, the pca gene cluster for the β-ketoadipate pathway inevitably 
functions for CAP in mycobacterial PAH metabolism (Figures 5C, 7B, 8, and 10B). 
A closer examination of the pca clusters from the members of PAH-degraders and PAH-non-
degraders provides additional evidence not only for a pivotal role of HGT but also for 
evolutionary dynamics of operon structures in the evolution of the PAH-degrading phenotype 
at the genus level (Figure 10B). Despite the benefits conferred by coregulation [74], the pca 
operon is not stable in composition over evolutionary time, as shown in Figure 10B. The 
pcaHGBLIJ genes seem to be resistant for operon breakage in all PAH-degraders, although 
the gene pcaF, encoding β-ketoadipyl-CoA thiolase, the last step enzyme to transform β-
ketoadipyl-CoA to succinyl-CoA and acetyl-CoA in the β-ketoadipate pathway [9,75], does 
not reside in the pca cluster. In the PAH-non-degraders Mycobacterium sp. JDM601, M. 
avium 104, and M. avium subsp. paratuberculosis K-10, these operons are drastically 
reduced, having lost several genes, such as pcaL, pcaI, pcaJ, and pcaF (Figure 10B). 
However, although several pca genes are found in the genomes of other PAH-non-degraders, 
they are completely dispersed (Figures 8 and 10B). Especially, the two OI strains Br4923 and 
TN have completely lost pcaI, pcaJ, and pcaL (Figure 11). Therefore, stability of the pca 
operon structure is strongly correlated with the PHA-degrading ability of the genome, 
functioning as a useful indicator in the assessment of genome evolution in terms of the PAH-
degrading phenotype. 
A possible evolutionary path of the PAH-degrading phenotype in the genus 
Mycobacterium 
An integrated view of phylogeny, functional pan-genome, and MPN suggests that 
mycobacterial genomic dynamics has been communicated to the PAH-degrading phenotype 
according to its lifestyle. In the genus Mycobacterium, PAH-metabolism might be an 
attractive backup phenotype for alternative carbon-energy sources to free-living 
mycobacteria, but it seems to have been regarded as dispensable by the host-dependent 
species. In addition, due to PAH metabolic ambiguity (as nutrient or toxicant), its evolution 
might not have been simple or even random. The observed gene gain/loss patterns by HGT 
and deletion hypothesize a possible evolutionary path in which mycobacteria have obtained 
and preserved the extra metabolic capability while free-living, but during evolution towards 
the host-dependent life lost this dispensable capability (Figure 12). 
Figure 12 A plausible evolutionary pathway of the PAH-degrading mycobacterial 
group. The scheme is based on the gene gain and loss of PAH-degrading genes and the 
genomic information (genome and pan-genomes). The size of circles indicates the ratio of the 
relative size of the genomes. The complete black circles indicate a mycobacterium with the 
complete gene set for PAH-degradation, while partially blacked circles indicate PAH-non-
degrading mycobacteria with incomplete PAH-degrading genes. More filled circles mean 
more PAH-degrading genes in the genome. Color shading follows Figure 11. Note that all 
PAH-degrading mycobacteria have larger genome size and more HGT events than PAH-non-
degrading mycobacteria, which have some PAH-degrading genes but not a complete set of 
genes. Especially, OI mycobacteria have the smallest size in terms of genome and the number 
of PAH-degrading genes. Under strong natural selection, the gene gain/loss by HGT/deletion 
events hypothesize an epistasis-based birth (from CAP to RCP via SCP) and pleiotropy-
dependent death (from RCP and CAP to SCP), for PAH metabolism in the genus 
Mycobacterium. 
Epistasis-based origin of the mycobacterial PAH-degrading phenotype 
Genomic evidence from the 27 fully-sequenced mycobacteria strongly suggests extensive 
HGT events of the genetic materials related to PAH metabolism in the environment. 
Furthermore, the genus Mycobacterium originally had several metabolic and physiological 
selective advantages along with this new metabolic phenotype: (i) high specific affinity for 
PAH substrates, (ii) cell surface hydrophobicity and attachment ability, and (iii) formation of 
biofilms on PAH particles [4,5,14,15]. Despite such selective advantages, however, the 
energy required to acquire a PAH-degrading phenotype seems excessively high. For example, 
for the four ring-structure pyrene to be completely degraded in the PAH-MN, the genomic 
HGT evidence in this study and the previously proposed evolution hypothesis of the 
metabolic network suggest that at least 5 different HGT events are required, which should 
successfully provide the building blocks for a patchwork assembly to cover the entire 27 
metabolic steps [6,7]. Actually, since the HGT events can in principle occur in any order, 
there are 5! = 120 HGT trajectories linking the gene clusters. However, toxic effects of the 
uncontrolled intermediates, such as o-quinones [18], might not regard all trajectories 
equivalently. Therefore, productive epistatic interactions of the building blocks should have a 
strong selection impact on the evolutionary trajectories. Consistent with this opinion, the 
conserved genetic sources with similar gene cluster structures in the core-genome of the 
PAH-degrading mycobacteria suggest overlapping evolutionary events and evolutionary 
trajectories for the PAH-degrading phenotype. Under strong natural selection towards 
minimized side effects, impacts of the epistatic interaction of the genetic sources might 
restrict the possible evolutionary trajectories for mycobacteria to be able to obtain the PAH 
metabolic ability. Hence, all the successful evolutionary trajectories were able to satisfy the 
functionally reversed growth of the PAH-MN: a patchwork assembly with a growth direction 
from CAP to RCP via SCP, essential to minimize the toxic effects of the activated PAH 
intermediates, which are produced in the RCP [9] (Figures 11 and 12). 
Pleiotropy-dependent abandonment of the mycobacterial PAH-degrading 
phenotype 
Despite a high degree of technical difficulty in obtaining a PAH-degrading ability, it could be 
an attractive phenotype for free-living mycobacteria in terms of nutritional competition in 
oligotrophic environmental niches [5,20]. On the other hand, the PAH-degrading phenotype 
might be unnecessary to host-dependent mycobacteria, which do not obtain nutritional 
benefits from PAH substrates. For example, M. tuberculosis, an intracellular pathogen, uses 
fatty acids and cholesterol from its host [76]. Interestingly, as revealed in the gene gain/loss 
analysis (Figure 11), there is a clear negative correlation between the size of genetic remnants 
related to PAH metabolism and the evolutionary time toward the host-dependent life, which 
suggests the basic evolutionary concept—initially adopted but later abandoned—for the 
PAH-degrading phenotype in the genus Mycobacterium (Figure 12). The instability of the 
operon structures remaining in the genomes of the host-dependent mycobacteria and the lack 
of certain genes for PAH catabolic function suggest abandonment of the PAH-degrading 
phenotype in the evolution towards a host-dependent lifestyle. Because PAHs are absent in 
the biological hosts, it is likely that this ability has been lost during the host-dependent 
evolution. 
We observed the early events in the disassembly of the PAH-MN in the FHA PAH-non-
degrading mycobacterial genomes (Mycobacterium sp. JDM601, M. avium 104, and M. 
avium subsp. paratuberculosis K-10), which are located in the middle of the free-living PAH-
degraders and the FHA M. tuberculosis complex, while there was a rare opportunity to 
observe the genetic evidence from the free-living PAH-degrading mycobacteria (Figures 10 
and 11). As shown in Figure 10, the operons having genes involved in the pht and β-
ketoadipate pathways, respectively, according to the PAH-metabolic ability showed different 
stability; the two operons are protected from breakage in the PAH-degrading strains but are 
broken in the PAH-non-degrading mycobacterial genomes. 
Like the origin of PAH-MN discussed above, the same strength of natural selection 
minimizing toxic side effects might also have restricted the abandonment trajectories in the 
evolutionary process for disuse of the dispensable metabolic capability in the host-dependent 
mycobacteria. Evolutionary rational endeavors seem to have participated in the disassembly 
process to follow the effective abandonable trajectories to minimize any possible side-effects 
and to save time and energy. In this respect, the effects of genetic perturbation on functional 
robustness—correlation between functional redundancy and negative epistasis—from the 
perspective of quantity and quality in the metabolism of PAHs provide clues to understand 
the plausible abandonment trajectories. Although the PAH-degrading phenotype is 
functionally robust to genetic perturbation, the robustness depends mainly on perturbation 
location in the PAH-MN. The funnel-like topology of the MN is intimately related to its 
behavior and also to its functional robustness toward genetic perturbation, in which many 
peripheral pathways converge to the β-ketoadipate pathway with the same input and output 
diameters in its function, which is linked to the TCA cycle [9]. In general, effects of the 
functional perturbation on the steps, with extremely low genetic and functional redundancy, 
propagate across the entire PAH-MN, creating many possible quantitative metabolic 
damages. In this respect, as revealed in the pan-genomic and RHO profile comparison, the 
host-dependent mycobacteria seem to have followed the effective abandonment trajectories, 
which initially tried to have the RHO systems disabled from the RCP modules, responsible 
mainly for toxic PAH intermediates. However, from the negative epistatic interaction view, 
RHO systems in the PAH-MN are not good target genes for effective abandonment 
trajectories, considering their extremely high genetic and functional redundancy. 
Surprisingly, the host-dependent mycobacteria seem to find the best solution for this 
problematic requirement from the common feature of mycobacterial RHO systems, which is 
numerical imbalance between the two functional groups, an oxygenase and an ETC. 
[9,67,68]. As shown in Figure 13, the distinct numerical imbalance between oxygenase 
components and an ETC. clearly indicates that a gene encoding the ETC. has strong 
functionally pleiotropic effects. Based on these observations, the practical metabolic effects 
of the gene loss for a type V ETC. could be significant and effective. Especially, considering 
their responsibility for the initial ring-hydroxylation of PAH substrates in diverse RCP 
functional modules (Figure 13), which produce activated toxic intermediates, removal of the 
RHO function by loss of the strong pleiotropic gene could be effective and time-saving, as 
observed in the metabolic and proteomic data of PAH-MN [9]. In addition, the three type V 
RHO enzymes, two Nid systems and a Pdo system responsible mainly for the initial 
oxygenation of diverse PAH substrates are absent in all PAH-non-degraders. Together with 
these endeavors, the PAH-non-degraders have kept the enzymes responsible for 
detoxification. For example, more genes encoding COMTs, involved in the detoxification of 
toxic PAH intermediates, exist in the PAH-non-degraders (Figure 8). 
Figure 13 Scale-free functional interaction network of the enzymes responsible for RCP 
in the PAH-MN. The functional network was reconstructed based on the enzymes involved 
in the RCP in PAH-MN, which are expressed as proteins and exist in the core-genome of the 
PAH-degraders (that is, selected by functional pan-genomics). In the network, the size of 
nodes is based on the degree of connectivity of the nodes. The main hub node, PhtAc, which 
shows the highest connectivity with an in-degree of 1 and out-degree of 16, is shown as the 
biggest node in size. Cytoscape was used for visualizing and analyzing networks in this study 
[77]. 
Taken together, these systematic observations offer strong support for the hypothesis that 
natural selection for maximized metabolic benefits and minimized side effects of the 
uncontrolled PAH intermediates has restricted the evolutionary trajectories of mycobacterial 
PAH metabolism. The evolutionary behavior might take full advantage of the pleiotropic and 
epistatic effects of gene gain/loss, allowing mycobacteria to follow the few successful 
trajectories, which satisfy the functional and toxicological requirements in the evolution of 
PAH metabolism in the genus Mycobacterium. 
Conclusions 
Taking the whole picture into account, mycobacterial PAH metabolism at the genus level 
might be an excellent phenotypic model to bridge genomic dynamics and phenotypic 
evolution, which could address a series of questions for a predictable direction and plausible 
trajectories for mycobacterial evolution. The reasonable factors and their practical advantages 
include the following: (i) the metabolic ambiguity of PAHs as carbon and energy sources or 
toxicants, which might have directed evolutionary responses to maximize the nutritional 
benefits and minimize the possible side-effects, enhancing opportunities to observe the 
apparently selective choice of evolutionary trajectories; (ii) the availability (ubiquity) of 
PAHs in the environment but not in the biological hosts, which might be an apparent 
selective pressure on its evolution; (iii) the flood of genome sequences and phenotypic 
information across strains from free-living to obligate intracellular parasites, together with the 
complete metabolic and genetic knowledge for mycobacterial PAH metabolism, which allow 
synergistic analysis of phylogenic, phenotypic, and genomic information going into the 
structure, behavior, and evolution of PAH metabolism. 
In this study, we have discovered a wealth of evidence relating mycobacterial evolution to 
PAH metabolism. This evidence comes in a useful mycobacterial compendium of phenotypic 
and genomic changes, focusing on the PAH-degrading phenotype with a functional pan-
genomic perspective of the evolutionary events and environmental challenges. The 
compendium enabled us to understand the relation between genomic dynamics and the 
corresponding phenotypic effects, which helped us to follow a few plausible evolutionary 
paths to fitter phenotypes. When selection acts on evolution of PAH metabolism, only a small 
fraction of evolutionary trajectories are likely to be observed, owing mainly to a combination 
of the ambiguous metabolic effects of PAHs and the corresponding pleiotropy- and epistasis-
dependent evolutionary behavior. Systematic functional pan-genomic comparison allows us 
to follow largely identical evolutionary trajectories, which substantially enriches our 
understanding of the pleiotropic and epistatic evolutionary process of PAH metabolism at the 
genus level. Evolutionary constraints on the trajectories seen in the PAH-degrading 
phenotype are likely to apply to the evolution of other phenotypes in the genus 
Mycobacterium, which is essential to better characterize mycobacterial communities for 
medical or bioengineering applications. 
Methods 
Genome sequences and proteomic data sets 
In this study, we used only complete genome sequences with well-organized phenotypic and 
genomic information (Table 1) for reasonable network and functional pan-genomic analysis 
without numerical bias in terms of mycobacterial phenotypes. All genome sequences were 
retrieved from the NCBI (http://www.ncbi.nlm.nih.gov/genome/browse/) or IMG/JGI 
(https://img.jgi.doe.gov/cgi-bin/w/main.cgi). The NCBI gbk and ptt (a tab delimited file 
containing a list of all the proteins for the genome) files of the 27 genome sequences were 
obtained from the NCBI ftp site (ftp://ftp.ncbi.nih.gov/genomes/) to generate a master 
genome table for gene annotation and COG analysis of the pan-genome and proteomic data 
sets. For functional pan-genomic comparison, the proteomic data sets of M. vanbaalenii 
PYR-1 (DSM 7251) treated with phthalate, the LMW PAHs fluorene, acenaphthylene, 
anthracene, and phenanthrene, and the HMW PAHs pyrene and benzo[a]pyrene, were used to 
select the genes which are expressed as proteins from the pan-genomic data [6-9,67,68]. 
Genome comparison 
Basic comparative genome analyses, including genome clustering based on COG 
information, were conducted using the JGI Integrated Microbial Genomes (IMG) system 
(https://img.jgi.doe.gov/cgi-bin/w/main.cgi). To visualize the function-based genomic 
comparison, the 27 mycobacterial genomes were clustered based on functional profiles; the 
PCA clustering analysis was conducted using the genome clustering function of the JGI IMG 
system (https://img.jgi.doe.gov/cgi-bin/w/main.cgi) with the condition: clustering type, COG 
and clustering method, Principal Components Analysis (PCA). Proximity of grouping 
indicates the similarity of genomes. 
Pan-genome (core and pan-genome) and Venn diagram analyses of the pan-genomic data sets 
were conducted using EDGAR [78]. The core and pan-genome were computed by iterative 
pairwise comparison of a set of genomes. Using the metacontig function of EDGAR, we also 
defined custom groups of genomes for which the core genome or the pan genome have been 
stored as virtual contigs. A total of 9 virtual contigs according to the phenotype grouping of 
the 27 mycobacterial genomes was used in all subsequent EDGAR calculations, including 
Venn diagram analysis. 
Phylogenetic analysis 
For a concatenated phylogenetic tree, we selected the 22 common genes from the core 
genome in the 27 mycobacterial strains [79] and estimated phylogenetic relationships. The 22 
genes include (locus tags from M. vanbaalenii PYR-1); Mvan_0002, Mvan_1234, 
Mvan_1235, Mvan_1236, Mvan_1258, Mvan_1280, Mvan_1282, Mvan_1305, Mvan_1308, 
Mvan_1311, Mvan_1312, Mvan_1334, Mvan_1337, Mvan_1339, Mvan_1347, Mvan_1434, 
Mvan_1435, Mvan_1436, Mvan_1470, Mvan_1489, Mvan_2209, and Mvan_2651. 
Phylogenetic trees were constructed by the maximum likelihood method using PhyML [80] 
with the following parameters: (1) input data: the concatenated DNA sequences of the 22 
common genes; (2) substitution model: HKY85 with substitution rate categories of 4 and 
estimated gamma shape parameter; (3) tree searching: BIONJ for starting tree and NINI for 
tree improvement with optimizing of topology and branch lengths; and (4) bootstrap: 100. 
MEGA4 [81] was used to visualize and manipulate the output trees. 
Gain/loss analysis of the PAH-degrading genes 
The gain and loss of the PAH-degradation gene groups (a total of 23 groups) was assessed 
using the Count software [72] based on the PAH-degrading genes matrix across the genus 
Mycobacterium (Additional file 4: Table S13 and Additional file 5: Table S14). The Wagner 
parsimony model implemented in Count with the gain penalty of 1 was used to reconstruct 
gene content evolution in the history of the PAH-degrading gene groups as well as four types 
of the RHO group. The phylogenetic tree constructed by the maximum likelihood method 
(Figure 2A) was used as the guide topology. 
Ring hydroxylating oxygenase (RHO) classification 
For classification and comparison of mycobacterial RHO enzymes, we used ClassRHO [67-
69], which performs hierarchical cluster analysis using pairwise distance (PD) matrices and 
calculated from ClustalW default protein weight matrix (Blosum). For the classification of 
246 RHO systems from the 27 mycobacterial strains, we used the automatic optimal 
threshold value that maximizes the learning accuracy. In the analysis, together with 42 
standard RHO sequences, the amino acid sequences of large (α) subunits from the 246 RHO 
systems were used as RHO query sequences. 
Genomic island (GI) analysis 
For computational identification, comparison, and visualization of genomic islands from the 
mycobacterial genomes, we used IslandViewer [82], a computational tool which integrates 
three different genomic island prediction methods, IslandPick [82], SIGI-HMM [83], and 
IslandPath-DIMOB [84]. 
Network model of the relationships of the mycobacterial phenotypes 
To model relationships and strengths among the nine phenotypes (Free-Living, PAH-
degrading, Fast-growing, Non-pathogenic, Facultatively-host-associated, PAH-non-
degrading, Pathogenic, Slow-growing, and Obligately intracellular), we reconstructed a 
network, Mycobacterial Phenotype Network (MPN). Basically, the network consists of nodes 
(vertices) and connections (edges) to represent mycobacteria and their relations, respectively. 
Since the phenotypes seem to be disjoint or individual sets, whose nodes (i.e. mycobacteria) 
can be partitioned into subsets, the structure between two groups (phenotypes) is loosely 
based on a bipartite graph. Seemingly, in the MPN several bipartite graphs are interrelated; 
however, different phenotypes may have identical mycobacteria, which are represented by 
individual nodes in each phenotype, to model the relationships. To represent the 
relationships, we connect the nodes between two phenotypes only if they are identical 
mycobacteria, i.e. the same mycobacterial occurrence/event between two phenotypes. In the 
MPN, the connection is undirected since it includes no distinction or causality between the 
nodes. Intuitively, in the MPN, the greater the number of edges between groups, the stronger 
the connection is. We define the connection strength between two groups, Gx and Gy, as CS 
(Gx, Gy), defined as 
,	 
 ρ	  ρ	  50  
where ρ (Gx) is the percentage of nodes in Gx with edges to Gy. 
For visualizing and analyzing networks in this study, Cytoscape [77] was used. In the MPN, 
the thickness of edge between two phenotype groups is based on the degree of the connection 
strength (CS value). 
Availability of supporting data 
The data sets supporting the phylogenetic result of this article are available on the TreeBASE 
repository, ID: S16971, http://purl.org/phylo/treebase/phylows/study/TB2:S16971. 
Abbreviations 
PAHs, polycyclic aromatic hydrocarbons; HMW, high-molecular-weight; LMW, low-
molecular-weight; HGT, horizontal gene transfer; PAH-MN, PAH metabolic network; MPN, 
mycobacterial phenotype network; FL, free-living; FHA, facultatively-host-associated; OI, 
obligately intracellular; RHO, ring-hydroxylating oxygenase; ETC, electron transfer 
component; PN, phenotype network; COG, cluster of orthologous groups; CYP, cytochrome 
P450 monooxygenase; RCD, ring-cleavage dioxygenase; PCA, principal components 
analysis; PD, pairwise distance; NCBI, National Center for Biotechnology Information; IMG, 
Integrated Microbial Genomes; JGI, Joint Genome Institute 
Competing interests 
The authors declare that they have no competing interests. 
Authors’ contributions 
OK, SK, JBS, and CEC conceived the project, designed research, performed research, 
analyzed data, and wrote the manuscript; JB designed research (Pan-genome analysis) and 
wrote the manuscript; SKK, BSK, and DHB analyzed data (database and phylogeny) and 
wrote the manuscript. All authors read and approved the final manuscript. 
Acknowledgements 
We thank Kuppan Gokulan and Mark Hart for critical review of the manuscript. We also 
thank Dr. Joshua Xu for his statistical advice. This work was supported in part by an 
appointment to the Postgraduate Research Fellowship Program at the National Center for 
Toxicological Research, administered by the Oak Ridge Institute for Science and Education 
through an interagency agreement between the U. S. Department of Energy and the U. S. 
Food and Drug Administration. The views presented in this article do not necessarily reflect 
those of the U.S. FDA. 
References 
1. Rastogi N, Legrand E, Sola C. The mycobacteria: an introduction to nomenclature and 
pathogenesis. Rev Sci Tech. 2001;20:21–54. 
2. Hartmans S, De Bont JA, Stackebrandt E. The genus Mycobacterium-nonmedical. 3rd ed. 
New York, NY: Springer Verlag; 2006. 
3. Saviola B, Bishai W. The genus Mycobacterium-medical. In: Falkow S, Rosenberg E, 
Schleifer K-H, Stackebrandt E, editors. The Prokaryotes. 3rd ed. New York, NY: Springer 
Verlag; 2006. p. 919–33. 
4. Glickman MS, Jacobs Jr WR. Microbial pathogenesis of Mycobacterium tuberculosis: 
dawn of a discipline. Cell. 2001;104:477–85. 
5. Kim SJ, Kweon O, Cerniglia CE. Degradation of polycyclic aromatic hydrocarbons by 
Mycobacterium strains. In: Timmis KN, editor. Handbook of hydrocarbon and lipid 
microbiology, vol. 3. Braunschweig, Germany: Springer; 2010. p. 1865–80 [McGenity T 
(Series Editor): Microbes and Communities Utilizing Hydrocarbons, Oils and Lipids]. 
6. Kim SJ, Kweon O, Jones RC, Freeman JP, Edmondson RD, Cerniglia CE. Complete and 
integrated pyrene degradation pathway in Mycobacterium vanbaalenii PYR-1 based on 
systems biology. J Bacteriol. 2007;189:464–72. 
7. Kweon O, Kim SJ, Jones RC, Freeman JP, Adjei MD, Edmondson RD, et al. A polyomic 
approach to elucidate the fluoranthene degradative pathway in Mycobacterium vanbaalenii 
PYR-1. J Bacteriol. 2007;189:4635–47. 
8. Kim SJ, Song J, Kweon O, Holland RD, Kim DW, Kim JN, et al. Functional robustness of 
a polycyclic aromatic hydrocarbon metabolic network examined in a nidA aromatic ring 
hydroxylating oxygenase mutant of Mycobacterium vanbaalenii PYR-1. Appl Environ 
Microbiol. 2012;78:3715–23. 
9. Kweon O, Kim SJ, Holland RD, Chen H, Kim DW, Gao Y, et al. Polycyclic aromatic 
hydrocarbon-metabolic network in Mycobacterium vanbaalenii PYR-1. J Bacteriol. 
2011;193:4326–37. 
10. DeBruyn JM, Mead TJ, Sayler GS. Horizontal transfer of PAH catabolism genes in 
Mycobacterium: evidence from comparative genomics and isolated pyrene-degrading 
bacteria. Environ Sci Technol. 2011;46:99–106. 
11. Badejo AC, Choi CW, Badejo AO, Shin KH, Hyun JH, Lee YG, et al. A global proteome 
study of Mycobacterium gilvum PYR-GCK grown on pyrene and glucose reveals the 
activation of glyoxylate, shikimate and gluconeogenetic pathways through the central carbon 
metabolism highway. Biodegradation. 2013;24:741–52. 
12. Miller CD, Hall K, Liang YN, Nieman K, Sorensen D, Issa B, et al. Isolation and 
characterization of polycyclic aromatic hydrocarbon-degrading Mycobacterium isolates from 
soil. Microb Ecol. 2004;48:230–8. 
13. Kallimanis A, Karabika E, Mavromatis K, Lapidus A, Labutti KM, Liolios K, et al. 
Complete genome sequence of Mycobacterium sp. strain (Spyr1) and reclassification to 
Mycobacterium gilvum Spyr1. Stand Genomic Sci. 2011;5:144–53. 
14. Kweon O, Kim SJ, Cerniglia CE. Genomic view of mycobacterial high molecular weight 
polycyclic aromatic hydrocarbon degradation. In: Timmis KN, editor. Handbook of 
hydrocarbon and lipid microbiology, vol. 2. Braunschweig, Germany: Springer; 2010. p. 
1165–78. 
15. Kweon O, Kim SJ, Freeman JP, Song J, Baek S, Cerniglia CE. Substrate specificity and 
structural characteristics of the novel Rieske nonheme iron aromatic ring-hydroxylating 
oxygenases NidAB and NidA3B3 from Mycobacterium vanbaalenii PYR-1. MBio. 
2010;1:e00135–10. 
16. Ostman B, Hintze A, Adami C. Impact of epistasis and pleiotropy on evolutionary 
adaptation. Proc Biol Sci. 2012;279:247–56. 
17. Heitkamp MA, Freeman JP, Miller DW, Cerniglia CE. Pyrene degradation by a 
Mycobacterium sp.: identification of ring oxidation and ring fission products. Appl Environ 
Microbiol. 1988;54:2556–65. 
18. Kim YH, Moody JD, Freeman JP, Brezna B, Engesser KH, Cerniglia CE. Evidence for 
the existence of PAH-quinone reductase and catechol-O-methyltransferase in Mycobacterium 
vanbaalenii PYR-1. J Ind Microbiol Biotechnol. 2004;31:507–16. 
19. Kim SJ, Jones RC, Cha CJ, Kweon O, Edmondson RD, Cerniglia CE. Identification of 
proteins induced by polycyclic aromatic hydrocarbon in Mycobacterium vanbaalenii PYR-1 
using two-dimensional polyacrylamide gel electrophoresis and de novo sequencing methods. 
Proteomics. 2004;4:3899–908. 
20. Cerniglia CE. Biodegradation of polycyclic aromatic hydrocarbons. Biodegradation. 
1992;3:351–68. 
21. Kanaly RA, Harayama S. Advances in the field of high-molecular-weight polycyclic 
aromatic hydrocarbon biodegradation by bacteria. Microb Biotechnol. 2011;3:136–64. 
22. Cheung PY, Kinkle BK. Mycobacterium diversity and pyrene mineralization in 
petroleum-contaminated soils. Appl Environ Microbiol. 2001;67:2222–9. 
23. Tyler AL, Asselbergs FW, Williams SM, Moore JH. Shadows of complexity: what 
biological networks reveal about epistasis and pleiotropy. Bioessays. 2009;31:220–7. 
24. Zakham F, Aouane O, Ussery D, Benjouad A, Ennaji MM. Computational genomics-
proteomics and Phylogeny analysis of twenty one mycobacterial genomes (Tuberculosis & 
non Tuberculosis strains). Microb Inform Exp. 2012;2:7. 
25. Jena L, Kumar S, Harinath BC. MycoProtease-DB: useful resource for Mycobacterium 
tuberculosis complex and nontuberculous mycobacterial proteases. Bioinformation. 
2012;8:1240–2. 
26. Kim YH, Engesser KH, Cerniglia CE. Numerical and genetic analysis of polycyclic 
aromatic hydrocarbon-degrading mycobacteria. Microbial Ecol. 2005;50:110–9. 
27. Khan AA, Kim SJ, Paine DD, Cerniglia CE. Classification of a polycyclic aromatic 
hydrocarbon-metabolizing bacterium, Mycobacterium sp. strain PYR-1, as Mycobacterium 
vanbaalenii sp. nov. Int J Syst Evol Microbiol. 2002;52:1997–2002. 
28. Dean-Ross D, Cerniglia CE. Degradation of pyrene by Mycobacterium flavescens. Appl 
Microbiol Biotechnol. 1996;46:307–12. 
29. Zakham F, Belayachi L, Ussery D, Akrim M, Benjouad A, El Aouad R, et al. 
Mycobacterial species as case-study of comparative genome analysis. Cell Mol Biol (Noisy-
le-Grand). 2011;57(Suppl):OL1462–9. 
30. Zhang ZY, Sun ZQ, Wang ZL, Hu HR, Wen ZL, Song YZ, et al. Identification and 
pathogenicity analysis of a novel non-tuberculous Mycobacterium clinical isolate with nine-
antibiotic resistance. Clin Microbiol Infect. 2013;19:91–6. 
31. Stinear TP, Seemann T, Harrison PF, Jenkin GA, Davies JK, Johnson PD, et al. Insights 
from the complete genome sequence of Mycobacterium marinum on the evolution of 
Mycobacterium tuberculosis. Genome Res. 2008;18:729–41. 
32. Stinear TP, Seemann T, Pidot S, Frigui W, Reysset G, Garnier T, et al. Reductive 
evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the 
causative agent of Buruli ulcer. Genome Res. 2007;17:192–200. 
33. Stinear TP, Mve-Obiang A, Small PL, Frigui W, Pryor MJ, Brosch R, et al. Giant 
plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium 
ulcerans. Proc Natl Acad Sci U S A. 2004;101:1345–9. 
34. Torrelles JB, Ellis D, Osborne T, Hoefer A, Orme IM, Chatterjee D, et al. 
Characterization of virulence, colony morphotype and the glycopeptidolipid of 
Mycobacterium avium strain 104. Tuberculosis (Edinb). 2002;82:293–300. 
35. Horan KL, Freeman R, Weigel K, Semret M, Pfaller S, Covert TC, et al. Isolation of the 
genome sequence strain Mycobacterium avium 104 from multiple patients over a 17-year 
period. J Clin Microbiol. 2006;44:783–9. 
36. Ripoll F, Pasek S, Schenowitz C, Dossat C, Barbe V, Rottman M, et al. Non 
mycobacterial virulence genes in the genome of the emerging pathogen Mycobacterium 
abscessus. PLoS One. 2009;4:e5660. 
37. Geluk A, Klein MR, Franken KL, van Meijgaarden KE, Wieles B, Pereira KC, et al. 
Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to 
improve immunodiagnosis of infection. Infect Immun. 2005;73:5636–44. 
38. Li L, Bannantine JP, Zhang Q, Amonsin A, May BJ, Alt D, et al. The complete genome 
sequence of Mycobacterium avium subspecies paratuberculosis. Proc Natl Acad Sci U S A. 
2005;102:12344–9. 
39. Paustian ML, Zhu X, Sreevatsan S, Robbe-Austerman S, Kapur V, Bannantine JP. 
Comparative genomic analysis of Mycobacterium avium subspecies obtained from multiple 
host species. BMC Genomics. 2008;9:135. 
40. Bentley SD, Comas I, Bryant JM, Walker D, Smith NH, Harris SR, et al. The genome of 
Mycobacterium africanum West African 2 reveals a lineage-specific locus and genome 
erosion common to the M. tuberculosis complex. PLoS Negl Trop Dis. 2012;6:e1552. 
41. Hosen MI, Tanmoy AM, Mahbuba DA, Salma U, Nazim M, Islam MT, et al. Application 
of a subtractive genomics approach for in silico identification and characterization of novel 
drug targets in Mycobacterium tuberculosis F11. Interdiscip Sci. 2014;6:48–56. 
42. Philipp WJ, Nair S, Guglielmi G, Lagranderie M, Gicquel B, Cole ST. Physical mapping 
of Mycobacterium bovis BCG Pasteur reveals differences from the genome map of 
Mycobacterium tuberculosis H37Rv and from M. bovis. Microbiology. 1996;142:3135–45. 
43. Philipp WJ, Poulet S, Eiglmeier K, Pascopella L, Balasubramanian V, Heym B, et al. An 
integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, 
and comparison with Mycobacterium leprae. Proc Natl Acad Sci U S A. 1996;93:3132–7. 
44. Cole ST, Barrell BG. Analysis of the genome of Mycobacterium tuberculosis H37Rv. 
Novartis Found Symp. 1998;217:160–72. discussion 172–167. 
45. Jiang Y, Liu HC, Zheng HJ, Tang B, Dou XF, Zhao XQ, et al. Evaluation of four 
candidate VNTR Loci for genotyping 225 Chinese clinical Mycobacterium tuberculosis 
complex strains. Biomed Environ Sci. 2012;25:82–90. 
46. Lu B, Dong HY, Zhao XQ, Liu ZG, Liu HC, Zhang YY, et al. A new multilocus 
sequence analysis scheme for Mycobacterium tuberculosis. Biomed Environ Sci. 
2012;25:620–9. 
47. Agarwal N, Bishai WR. cAMP signaling in Mycobacterium tuberculosis. Indian J Exp 
Biol. 2009;47:393–400. 
48. Vishnoi A, Roy R, Bhattacharya A. Comparative analysis of bacterial genomes: 
identification of divergent regions in mycobacterial strains using an anchor-based approach. 
Nucleic Acids Res. 2007;35:3654–67. 
49. Zhang Y, Chen C, Liu J, Deng H, Pan A, Zhang L, et al. Complete genome sequences of 
Mycobacterium tuberculosis strains CCDC5079 and CCDC5080, which belong to the Beijing 
family. J Bacteriol. 2011;193:5591–2. 
50. Mostowy S, Onipede A, Gagneux S, Niemann S, Kremer K, Desmond EP, et al. Genomic 
analysis distinguishes Mycobacterium africanum. J Clin Microbiol. 2004;42:3594–9. 
51. Gehre F, Otu J, DeRiemer K, de Sessions PF, Hibberd ML, Mulders W, et al. 
Deciphering the growth behaviour of Mycobacterium africanum. PLoS Negl Trop Dis. 
2013;7:e2220. 
52. Seki M, Honda I, Fujita I, Yano I, Yamamoto S, Koyama A. Whole genome sequence 
analysis of Mycobacterium bovis bacillus Calmette-Guerin (BCG) Tokyo 172: a comparative 
study of BCG vaccine substrains. Vaccine. 2009;27:1710–6. 
53. Garnier T, Eiglmeier K, Camus JC, Medina N, Mansoor H, Pryor M, et al. The complete 
genome sequence of Mycobacterium bovis. Proc Natl Acad Sci U S A. 2003;100:7877–82. 
54. Cole ST, Eiglmeier K, Parkhill J, James KD, Thomson NR, Wheeler PR, et al. Massive 
gene decay in the leprosy bacillus. Nature. 2001;409:1007–11. 
55. Eiglmeier K, Honore N, Woods SA, Caudron B, Cole ST. Use of an ordered cosmid 
library to deduce the genomic organization of Mycobacterium leprae. Mol Microbiol. 
1993;7:197–206. 
56. Monot M, Honore N, Garnier T, Zidane N, Sherafi D, Paniz-Mondolfi A, et al. 
Comparative genomic and phylogeographic analysis of Mycobacterium leprae. Nat Genet. 
2009;41:1282–9. 
57. Grange JM. The biology of the genus Mycobacterium. Soc Appl Bacteriol Symp Ser. 
1996;25:1S–9S. 
58. Macia J, Sole RV, Elena SF. The causes of epistasis in genetic networks. Evolution. 
2012;66:586–96. 
59. Merhej V, Royer-Carenzi M, Pontarotti P, Raoult D. Massive comparative genomic 
analysis reveals convergent evolution of specialized bacteria. Biol Direct. 2009;4:13. 
60. Medini D, Donati C, Tettelin H, Masignani V, Rappuoli R. The microbial pan-genome. 
Curr Opin Genet Dev. 2005;15:589–94. 
61. Sreevatsan S, Pan X, Stockbauer KE, Connell ND, Kreiswirth BN, Whittam TS, et al. 
Restricted structural gene polymorphism in the Mycobacterium tuberculosis complex 
indicates evolutionarily recent global dissemination. Proc Natl Acad Sci U S A. 
1997;94:9869–74. 
62. Brown-Elliott BA, Wallace Jr RJ. Clinical and taxonomic status of pathogenic 
nonpigmented or late-pigmenting rapidly growing mycobacteria. Clin Microbiol Rev. 
2002;15:716–46. 
63. Krzywinska E, Krzywinski J, Schorey JS. Naturally occurring horizontal gene transfer 
and homologous recombination in Mycobacterium. Microbiology. 2004;150:1707–12. 
64. Davids W, Zhang Z. The impact of horizontal gene transfer in shaping operons and 
protein interaction networks–direct evidence of preferential attachment. BMC Evol Biol. 
2008;8:23. 
65. de Visser JA, Cooper TF, Elena SF. The causes of epistasis. Proc Biol Sci. 
2011;278:3617–24. 
66. Kvitek DJ, Sherlock G. Reciprocal sign epistasis between frequently experimentally 
evolved adaptive mutations causes a rugged fitness landscape. PLoS Genet. 
2011;7:e1002056. 
67. Kweon O, Kim SJ, Baek S, Chae JC, Adjei MD, Baek DH, et al. A new classification 
system for bacterial Rieske non-heme iron aromatic ring-hydroxylating oxygenases. BMC 
Biochem. 2008;9:11. 
68. Kim SJ, Kweon O, Jones RC, Edmondson RD, Cerniglia CE. Genomic analysis of 
polycyclic aromatic hydrocarbon degradation in Mycobacterium vanbaalenii PYR-1. 
Biodegradation. 2008;19:859–81. 
69. Baek S, Kweon O, Kim SJ, Baek DH, Chen JJ, Cerniglia CE. ClassRHO: a platform for 
classification of bacterial Rieske non-heme iron ring-hydroxylating oxygenases. J Microbiol 
Methods. 2009;76:307–9. 
70. Kim SJ, Kweon O, Freeman JP, Jones RC, Adjei MD, Jhoo JW, et al. Molecular cloning 
and expression of genes encoding a novel dioxygenase involved in low- and high-molecular-
weight polycyclic aromatic hydrocarbon degradation in Mycobacterium vanbaalenii PYR-1. 
Appl Environ Microbiol. 2006;72:1045–54. 
71. Khan AA, Wang RF, Cao WW, Doerge DR, Wennerstrom D, Cerniglia CE. Molecular 
cloning, nucleotide sequence, and expression of genes encoding a polycyclic aromatic ring 
dioxygenase from Mycobacterium sp. strain PYR-1. Appl Environ Microbiol. 2001;67:3577–
85. 
72. Csuros M. Count: evolutionary analysis of phylogenetic profiles with parsimony and 
likelihood. Bioinformatics. 2010;26:1910–2. 
73. Brezna B, Kweon O, Stingley RL, Freeman JP, Khan AA, Polek B, et al. Molecular 
characterization of cytochrome P450 genes in the polycyclic aromatic hydrocarbon degrading 
Mycobacterium vanbaalenii PYR-1. Appl Microbiol Biotechnol. 2006;71:522–32. 
74. Price MN, Arkin AP, Alm EJ. The life-cycle of operons. PLoS Genet. 2006;2:e96. 
75. Harwood CS, Parales RE. The ß-ketoadipate pathway and the biology of self-identity. 
Annu Rev Microbiol. 1996;50:553–90. 
76. Niederweis M. Nutrient acquisition by mycobacteria. Microbiology. 2008;154:679–92. 
77. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a 
software environment for integrated models of biomolecular interaction networks. Genome 
Res. 2003;13:2498–504. 
78. Blom J, Albaum SP, Doppmeier D, Puhler A, Vorholter FJ, Zakrzewski M, et al. 
EDGAR: a software framework for the comparative analysis of prokaryotic genomes. BMC 
Bioinformatics. 2009;10:154. 
79. Battistuzzi FU, Feijao A, Hedges SB. A genomic timescale of prokaryote evolution: 
insights into the origin of methanogenesis, phototrophy, and the colonization of land. BMC 
Evol Biol. 2004;4:44. 
80. Guindon S, Dufayard JF, Lefort V, Anisimova M, Hordijk W, Gascuel O. New 
Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the 
Performance of PhyML 3.0. Syst Biol. 2010;59:307–21. 
81. Hall BG. Building phylogenetic trees from molecular data with MEGA. Mol Biol Evol. 
2013;30:1229–35. 
82. Langille MG, Brinkman FS. IslandViewer: an integrated interface for computational 
identification and visualization of genomic islands. Bioinformatics. 2009;25:664–5. 
83. Waack S, Keller O, Asper R, Brodag T, Damm C, Fricke WF, et al. Score-based 
prediction of genomic islands in prokaryotic genomes using hidden Markov models. BMC 
Bioinformatics. 2006;7:142. 
84. Hsiao W, Wan I, Jones SJ, Brinkman FSL. IslandPath: aiding detection of genomic 
islands in prokaryotes. Bioinformatics (Oxford, England). 2003;19:418–20. 
R
in
g
-c
le
av
ag
e 
p
ro
ce
ss
 (
R
C
P
) 
cis-Dihydrodiol
Cytochrome P450s (CYPs) &
Epoxide hydrolases
trans-Dihydrodiol
Dihydrodiol 
dehydrogenases
HO
OH
HO
OHH
H
HO
OHH
H
Ring-hydroxylating
Oxygenases (RHOs)
O˙
¯O
o-Semiquinone
anion radical
O
O
Catechol Quinone
H2O2
HO
OHH
H
O
Dihydrodiol
Epoxide
CYPs PAH-DNA adduct 
formation
HO
Ring-cleavage dioxygenase
PAHs
Ring-cleavage  products
O2˙¯O2˙¯
Oxidative DNA damage
O2
Carbon & energy sources
Growth rate
Pathogenicity
PAH-metabolism
Plasmid
Fast-growing Slow-growing 
Obligate 
Intracellular
Non-pathogenic
PAH-degrading
Pathogenic
PAH-non-degrading
1 2 3 2 1 1 1
Life-style Free-living Facultatively-host-associated
P
an
-g
en
om
e 
N
o.
 o
f g
en
es
(A)
(B)
(C)
P
hy
lo
ge
ne
tic
tr
ee Mycobacterium
sp. JD
M
601
M
.avium
 subsp paratuberculosis K
- 10
M
.africanum
 G
M
041182
M
.bovis
B
C
G
 str T
okyo 172
M
.bovis
B
C
G
 str P
asteur 1173P
2
M
. sm
egm
atis
str M
C
2 155
M
ycobacterium
 sp. M
C
S
M
ycobacterium
sp. K
M
S
M
ycobacterium
sp. JLS
M
. gilvum
 P
Y
R
- G
C
K
M
ycobacterium
.sp S
pyr1
M
.vanbaalenii P
Y
R
-1
M
.abscessus
M
. avium
104
M
.ulcerans
A
gy99
M
.m
arinum
 M
M
.canettiiC
IP
T
 140010059
M
.bovis
A
F
212297
M
.tuberculosis
K
Z
N
 1435
M
.tuberculosis
H
37R
v
M
. tuberculosis
C
D
C
1551
M
.tuberculosis
F
11
M
.tuberculosis H
37R
a
M
.tuberculosis C
C
D
C
5079
M
.tuberculosis
C
C
D
C
5180
M
.leprae B
r4923
M
.leprae T
N
100100100
100
100
100
94 100
100
100
100
77
85
73
88
75
99100
100
0
5K
10K
15K
20K
Core genome
Pan genome
M.smegmatis str MC2 155
M.abscessus
Mycobacterium sp. JLS
M. gilvum Spyr1
Mycobacterium sp. KMS
Mycobacterium sp. MCS
M.gilvum PYR-GCK
M.vanbaalenii PYR-1
M.avium 104
M.ulcerans Agy99
M.marinum M
Mycobacterium sp. JDM601
M.avium subsp paratuberculosis K-10
M.tuberculosis CCDC5079
M.tuberculosis CCDC5180
M.leprae TN
M.leprae Br4923
M.tuberculosis CDC1551
M.bovis BCG str Pasteur & Tokyo
M.tuberculosis KZN 1435
M.bovis AF212297
M.canettii CIPT 140010059
M.africanum GM041182
M.tuberculosis H37Ra & Rv
M.tuberculosis F11
P
C
A
 a
na
ly
si
s
(D)
PAH-
degrading (6) Fast-growing  (8)
FL (7)
Non-
pathogenic (7)
PAH-non-
degrading (21)
Slow-growing 
(19)
FHA (18)
Pathogenic (20)
OI (2)
87.5
92.9
92.9
93.8
100
9.5
9.5
42.3
9
8.8
92.9
95.2
55.3
55
95
97.4
54.8
97.5
(A)
Nodes
(B)
Non-pathogenic (7)
Fast-growing (8) PAH-degrading (6)
0
1013
2072
0
4480
N
o
. o
f 
g
en
es
2000
4000
6000
8000
10000
12000
14000
16000
0
3,533
(136)
Core-
genome
Dispensable
genome
5,999
Pan-genome (core + dispensable) 9,532
(A)
(B)
Dehydrodiol dehydrogenase
Ring-cleavage dioxygenase
Monooxygenase
Epoxide hydrolase
Catechol O-methyltransferase
RCP
(62)
SCP
(54)
CAP
(20)
Ring-hydroxylating oxygenase
Cytochrome P450
monooxygenase
Hydrolase
Alcohol dehydrogenase
Aldehyde dehydrogenase
Hydratase-aldolase
Decarboxylase
PcaBLIJ
PcaF
0 10
P
he
na
nt
hr
en
e
P
yr
en
e
F
lu
or
en
e
A
nt
hr
ac
en
e
B
en
z o
[a
]p
yr
en
e
A
ce
na
ph
th
yl
en
e
P
ht
ha
la
te
Module Enzyme
(C) COG functional category
N
o
. o
f 
g
en
es
Information
storage & 
Processing
Cellular processes
& signaling
Metabolism Poorly
characterized
(A)
(B)
2,878 genes
on GIs
754
2,124
Dispensable genome
Core
genome
(C)
N
o
. o
f 
g
en
es
PAH-degrading strain 
HGT genes 
in the core genome
HGT genes 
in the dispensable genome
N
o
. o
f 
g
en
es
COG functional category
Information
storage & 
Processing
Cellular processes
& signaling
Metabolism Poorly
characterized
(D)
Ring-cleavage 
dioxygenase (2)
RHO 
(7)
O P-450
(1)
OH
OH
Dehydrogenase 
(3)
Decarboxylase 
(1)
OH
CHO
COOH
CHO
COOH
COOH
Cn
OH
COOH
RCP
SCP
Epoxide 
hydrolase (1)
Dihydrodiol 
dehydrogenase (3) 
OHOH
OH
OH
OH
HOOC
O
H
COOH
COOH
COOH
Hydratase-aldolase (3)
Hydrolase (1)
(B)
(A)
K
L
D
M
O
T
V
C
E
G
H
I
P
Q
SCP
CAP
Information storage
& processing(18)
Cellular processes 
& signaling(32)
Metabolism
Poorly
Characterized(33)
Unknown 
function(94)
PAH metabolism
(48)
R
S
RCP
P
he
na
nt
hr
en
e
P
yr
en
e
F
lu
or
en
e
A
nt
hr
ac
en
e
C
on
tr
ol
B
en
z o
[a
]p
yr
en
e
A
ce
na
ph
th
yl
en
e
P
ht
ha
la
te
0 10
Function Code
(46)
6 PAH-
degrading 
mycobacteria
248
PG:16,433
CG:1,156
DG:15,277
PG:9,532
CG:3,533
DG:5,999
949
20 PAH-non-degrading 
mycobacteria
2,336
CG:3,533
PG:16,433
RCP
RHO COG4638
P450 COG2124
EP COG0596
DD COG1028
RCD
COG3435
COG0346
SCP
Decarboxylase COG0235
Hydratase-aldolase COG0329
CHO-Dehydrogenase COG1012
COMT COG3315
OH-Dehydrogenase
COG0604
COG1062
COG1063
COG1064
COG2130
Hydrolase
COG2267
COG0657
CAP
PcaB COG0015
PacF COG0183
PcaI COG1788
PcaJ COG2057
PcaG COG3485
PAH-metabolism
Life-style M
. lep
rae B
r4923
M
. lep
rae T
N
M
. tu
b
ercu
lo
sis H
37R
v
M
. tu
b
ercu
lo
sis K
Z
N
1435
M
. m
arin
u
m
 M
M
yco
b
acteriu
m
sp
. JD
M
601
M
. aviu
m
 p
aratu
b
ercu
lo
sis K
10
M
. aviu
m
 104
M
. sm
eg
m
atis M
C
2 155
M
. g
ilvu
m
 S
p
yr1
M
yco
b
acteriu
m
sp
. M
C
S
M
yco
b
acteriu
m
sp
. JL
S
M
yco
b
acteriu
m
sp
. K
M
S
M
. van
b
aalen
ii P
Y
R
-1
M
. g
ilvu
m
 P
Y
R
- G
C
K
M
. u
lceran
s A
g
y99
M
. tu
b
ercu
lo
sis C
D
C
1551
M
. tu
b
ercu
lo
sis F
11
M
. tu
b
ercu
lo
sis
H
37R
a
M
. b
o
vis
A
F
2122.97
M
. b
o
vis B
C
G
 T
o
kyo
172
M
. african
u
m
 G
M
041182
M
. can
ettii C
IP
T
 140010059
M
. b
o
vis B
C
G
.P
asteu
r.1173P
2
M
. tu
b
ercu
lo
sis
C
C
D
C
5180
M
. tu
b
ercu
lo
sis C
C
D
C
5079
M
. ab
scessu
s C
IP
 104536
FM COGEnzyme
(A)
T
B
F
G
 1
31
82
40230
G
M
B
T M
T
32
50
24
3
R
v3
16
1c
13
1
271
M
R
A
 3
19
4
62
1
JT
Y
 3
18
0
C
C
D
C
51
80
 2
87
7
C
C
D
C
50
79
 2
91
6
M
A
F
 3
17
00
B
C
G
 3
18
5c
M
b3
18
6c
19
7
16
8
17
0
16
0
47
1
51
2
M
C
A
N
 3
17
61
10
00
M
m
cs
 2
46
1
M
km
s 
25
06
10
00
M
jls
 2
49
8
10
00
M
flv
 3
08
2
M
sp
yr
1 
23
97
0
10
00
98
4
M
M
A
R
 4
42
2
10
00
M
S
M
E
G
 0
65
7
10
00
70
6
M
A
P
27
34
M
A
V
 3
50
9
10
00
JD
M
60
1 
27
08
99
4
M
m
cs
 1
62
2
M
km
s 
16
47
10
00
M
flv
 0
68
5
57
1
M
va
n 
04
63
77
9
M
jls
 1
59
5
M
sp
yr
1 
01
40
0
79
4
M
flv
 0
59
5
99
7
10
00
94
0
M
jls
 4
22
0
10
00
M
m
cs
 1
64
2
M
km
s 1
66
8
49
9
M
jls
 1
61
7
90
3
M
jls
 2
23
7
Mf
lv 
05
67
89
9
Mf
lv 
06
62
59
9
55
6
Mk
ms
 56
26
40
5
Mv
an
 04
88
Ms
py
r1 
01
62
0
56
9
10
00
Mm
cs
 16
66
Mj
ls 1
63
9
Mk
ms
 16
90
28
9
83
0
Mf
lv 0
55
8
Mfl
v 0
640
570
47
9
Mv
an 
052
5
541
Mk
ms
 56
39
Ms
pyr
1 0
184
0
61555
7
Mm
cs 5
458
Mkm
s 58
55
958100
0
Mkm
s 17
16
Mjls
 166
0
523 Mmc
s 16
89
929 Mflv
 053
7
Mspy
r1 02
060
921
766 Mvan
 0546
1000
999
100
0
10
00
Mmcs
 1673
Mflv 05
50
Mflv 06
32
Mjls 164
7
Mspyr1 0
1920
Mkms 1698
Mkms 5647
519503
4864
89475
1000
Mmcs 5450
Mkms 5847
1000
733
Mvan 0533
1000
Mvan 4415
MAB 4370c1000
672
Mjls 1653
Mflv 0544
532
Mvan 0539
493
Mkms 1709
497
Mmcs 1680
488
Mkms 5610
690
Mflv 0626
560
Mmcs 5441Mkms 5838
636
Mspyr1 01990
562
1000
995
618
Mjls 4195
978
Mmcs 1373
Mkms 1391
968
Mjls 1407
1000
Mflv 1355
Mspyr1 48230
1000
MSMEG 1908
918
1000
MAV 1901
Mjls 4071
943
MAV 2612
1000
MAV 5084
1000
987
714
Mmcs 1646
Mkms 1672
527
Mjls 1621
822
Mjls 2233
580
Mkms 5630
Mspyr1 01660
782
Mvan 0492
Mflv 0563
Mflv 0658
536
695
594
1000
663
M
AP0933
M
AV 1116
1000
M
van 4910
990
JDM
601 4212
1000
M
AP2336
M
AV 1644
1000
M
M
AR 3964
M
U
L 3820
1000
1000
1000
M
M
AR
 0230
M
U
L 4884
1000
994
761
TB
FG
 1
35
59
M
AF
 3
53
80
479
M
R
A
 3
56
5
B
C
G
 3
59
0
323
253
M
b3
55
6
R
v3
52
6
338
271
TB
M
G
 0
35
65
JT
Y
 3
59
1
440
720
C
C
D
C
50
79
 3
26
7
C
C
D
C
51
80
 3
21
9
483
423
M
C
A
N
 3
53
71
1000
M
A
V
 0
63
3
455
M
M
A
R
 5
01
5
M
U
L 
40
89
1000
999
M
km
s 
47
28
M
jls
 5
02
2
M
m
cs
 4
64
0
441
1000
612
M
flv
 1
53
3
M
sp
yr
1 
09
17
0
1000
M
va
n 
52
25
997
M
S
M
E
G
 5
92
5
999
723
JD
M
60
1 
36
68
873
3714
B
A
M
1000
6451
vlf
M
M
sp
yr
1 
09
30
0
0001
M
va
n 
52
11
10
00
M
A
B
 3
62
7c
10
00
846
M
A
P
14
34
M
A
V
 3
03
7
10
00
M
m
cs
 0
29
6
M
km
s 
03
06
83
2
M
jls
 0
28
7
10
00
M
flv
 4
56
6
M
sp
yr
1 
39
66
0
10
00
64
5 74
4
M
S
M
E
G
 2
87
0
M
va
n 
28
69
80
3
JD
M
60
1 
42
70
10
00
99
6
M
A
B
 0
08
0c
10
00
10
00
M
A
P
23
43
c
M
A
V
 1
63
8
10
00
M
M
A
R
 3
97
1
M
U
L 
38
29
10
00
10
00
M
A
P
23
77
M
A
V
 1
60
3
10
00
JD
M
60
1 
33
57
93
9
M
m
cs
 1
78
8
M
km
s 
18
35
98
5
M
jls
 1
76
9
10
00
M
flv
 4
33
3
M
sp
yr
1 
36
78
0
10
00
M
va
n 
20
12
98
7
M
SM
EG
 2
24
4
10
00
10
00
10
00
M
AP
28
82
c
M
AV
 3
66
6
10
00
JD
M
60
1 
16
15
91
0
M
M
AR
 1
93
5
MU
L 2
16
1
10
00
65
4
Mm
cs
 35
69
Mk
ms
 36
42
81
8
Mj
ls 
35
74
10
00
MS
ME
G 
07
34
99
1
59
0
Mf
lv 
27
53
Ms
py
r1 
21
92
0
10
00
Mv
an
 37
84
10
00
10
00
MA
B 0
72
6
10
00
MA
V 1
859
Mjl
s 4
116
100
0
MA
V 2
544
100
0
99
6
87
2
46
6
MA
V 1
857Mjls
 41
18
100
0
10
00
94
9
Mkm
s 23
05Mjls
 229
7
Mm
cs 2
258
508
1 0
0
MSM
EG 
4372
100
0
90
5
MAP
3076MAV
 389
1 1000
MSM
EG 2
343 805Mmcs
 5081Mk
ms 51
69 1000M
jls 546
0 1000M
van 158
1 383
Mflv 184
3Mspyr1 
12440
1000 356
1000
772
Mvan 1001
996
94
9
632
MAP0720c
MAV 0905
1000
JDM601 3503
749
MMAR 4744
1000
Mmcs 3747
Mkms 3820
810
Mjls 3759
1000
Mvan 4213
891
MSMEG 4840
1000
Mflv 2439
Mspyr1 18650 1000
1000
1000
MAP3141c
MAV 3967
000
Mmcs 3717
Mkms 3790
Mjls 3730
484
1000
Mflv 2464
Mspyr1 18900
1000
Mvan 4190
747
1000
MSMEG 0299
447
986
JDM601 3565
1000
919
MAP3136c
MAV 3961
1000
JDM601 3556
575
Mmcs 3710
Mkms 3783
977
Mjls 3723
1000
Mflv 2470
Mspyr1 18960
1000
Mvan 4184
616
1000
744
MSMEG 0293
1000
1000
70
0
Mmcs 3702
Mkms 3775
938
Mjls 3715
1000
Mflv 2328
Mspyr1 17610
1000
M
van 4319
541
1000
JDM
601 3445
1000
213
M
AP4315
M
AV 5278
1000
M
M
AR 0212
1000
M
van 0908
385
290
M
AP1484c
M
AV 2952
1000
M
AP3508
M
AV 5207
1000
JD
M
601 3523
694
M
S
M
E
G
 5627
M
m
cs 4406
M
km
s 4493
496
M
jls 4787
1000
M
flv 1788
M
spyr1 11720
1000
800
M
van 4962
1000553
1000
M
M
A
R
 0307
1000
Type V (36)
Type IV (2)
Type II (6)
Total 246 RHOs
Type X (202)
(B)
N
o
. o
f 
R
H
O
 g
en
e
PAH-degrading strain PAH-non-degrading strain 
(A)
(B)
Mycobacterium sp. MCS
Mycobacterium sp. KMS
Mycobacterium sp. JLS
M. gilvum PYR-GCK
Mycobacterium sp. Spyr1
M. vanbaalenii PYR-1
Mycobacterium sp. JDM601
M. avium subsp. paratuberculosis K-10
M. avium 104
pht operon
phtR phtAa phtAb phtB phtAd
PAH-degraders
PAH-non-degraders
0 kb 1 kb 2 kb 3 kb 4 kb 5 kb 6 kb
M. vanbaalenii PYR-1
Mycobacterium sp. JLS
Mycobacterium sp. KMS
Mycobacterium sp. MCS
Mycobacterium sp. Spyr1
M. gilvum PYR-GCK
Mycobacterium sp. JDM601
M. avium subsp. paratuberculosis K-10
M. avium 104
-ketoadipate operon
pcaH pcaG pcaB pcaL pcaI pcaJpcaR
PAH-degraders
PAH-non-degraders
0 kb 1 kb 2 kb 3 kb 4 kb 5 kb 6 kb
M. smegmatis MC2
Mycobacterium sp. JDM601
M.avium subsp paratuberculosis K-10
M.africanum GM041182
M.bovis BCG str Tokyo 172
M.bovis BCG str Pasteur 1173P2
M.smegmatis str MC2 155
Mycobacterium sp. MCS
Mycobacterium sp. KMS
Mycobacterium sp. JLS
M.gilvum PYR-GCK
Mycobacterium.sp Spyr1
M.vanbaalenii PYR-1
M.abscessus
M.avium 104
M.ulcerans Agy99
M.marinum M
M.canettii CIPT 140010059
M.bovis AF212297
M.tuberculosis KZN 1435
M.tuberculosis H37Rv
M.tuberculosis CDC1551
M.tuberculosis F11
M.tuberculosis H37Ra
M.tuberculosis CCDC5079
M.tuberculosis CCDC5180
M.leprae Br4923
M.leprae TN
1/0
21/21
22/21
23/22
23/21
21/21
23/22
23/22
23/21
23/22
23/21
23/22
20/17
22/21
22/20
22/21
21/18
21/20
20/16
20/16
20/16
20/16
20/16
20/16
20/16
20/16
20/16
20/16
20/16
20/15
15/8
15/8
20/16
20/16
23/22
23/22
15/8
22/20
21/18
20/16
20/16
20/16
20/16
20/16
20/16
20/16
20/16
20/16
21/18
20/16
22/20
22/21
22/21
22/21
1/0
0/5
0/2
1/0
0/1
0/1
free-living mycobacteria
Facultatively-host-associated
Obligately intracellular
(RCD)
(OH-DH4) (RCD)
(OH-DH4, PcaG)
(PcaG)
(OH-DH4)
(RHO [Type X], 
OH-DH2,
PcaI, PcaJ, PcaL)
V
II
IV
II IV V
II
V
X
Epistasis-based gene gain 
for CAP/SCP/RCP
Pleiotropy-dependent gene loss
for RCP/SCP/CAP
Gene loss
Environmental free-living mycobacteria
Host-dependent mycobacteria
Non-PAH-degrading
mycobacteria
(ex. M. smegmatis)
PAH-degrading
mycobacteria 
(ex. M. vanbaalenii PYR-1)
Non-PAH-degrading,
pathogenic mycobacteria
(ex. M. tuberculosis)
Non-PAH-degrading,
pathogenic mycobacteria 
(ex. M. leprae)
Ancestor
Facultatively-host-associated
Obligately intracellular
Free-living 
Gene loss
RHO systems
Dehydrodiol dehydrogenases
Ring cleavage dioxygenases
R
C
P
 in
th
e
P
A
H
-M
N
Additional files provided with this submission:
Additional file 1: Table S1. Core-genome analysis of the six PAH-degrading mycobacteria. Table S2. Functional analysis
of the 3,533-gene core-genome. Table S3. Analysis of 136 genes involved in PAH metabolism. Table S4. Protein expression
profile of 136 genes in M. vanbaalenii PYR-1. Table S5. List of 113 genes out of the 136 genes, which are expressed as
proteins involved in PAH degradation pathways (1044k)
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